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Abstract 
Microarray technology has revolutionized the field of molecular biology by offering an efficient and 
cost effective platform for the simultaneous quantification of thousands of genes or even entire 
genomes in a single experiment. Unlike southern blotting, which is restricted to the measurement of 
one gene at-a-time, microarrays offer biologists with the opportunity to carry out genome-wide 
experiments in order to help them gain a systems level understanding of cell regulation and control. 
The application of bioinformatics in the milieu of gene expression analysis has attracted a great deal 
of attention in the recent past due to specific algorithms and software solutions that attempt to 
illustrate complex multidimensional microarray data in a biologically coherent fashion so that it can 
be understood by the biologist. This has given rise to some exciting prospects for deciphering 
microarray data, by helping us refine our comprehension pertinent to the underlying physiological 
dynamics of disease. 
Although much progress is being made in the development of specialized bioinformatics software 
pipelines with the purpose of decoding large volumes of gene expression data in the context of 
systems biology, several loopholes exist. Perhaps most notable of these loopholes is the fact that there 
is an increasing demand for software solutions that specialize in automating the comparison of 
multiple gene expression profiles, derived from microarray experiments sharing a common biological 
theme. This is no doubt an important challenge, since common genes across different biological 
conditions having similar expression patterns are likely to be involved in the same biological process 
and hence, may share the same regulatory signatures. The potential benefits of this in refining our 
understanding of the physiology of disease are undeniable.  
The research presented in this thesis provides a systematic walkthrough of a series of software 
pipelines developed for the purpose of streamlining gene expression analysis in a systems biology 
context. Firstly, we present BiSAn, a software tool that deciphers expression data from the perspective 
of transcriptional regulation. Following this, we present Genome Interaction Analyzer (GIA), which 
analyzes microarray data in the integrative framework of transcription factor binding sites, protein-
protein interactions and molecular pathways. The final contribution is a software pipeline called 
MicroPath, which analyzes multiple sets of gene expression profiles and attempts to extract common 
regulatory signatures that may be implicating the biological question. 
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“Problems worthy of attack prove their 
worth by fighting back” 
 
Paul Erdos 
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Chapter 1 
Introduction 
 
1.1  Overview 
The completion of the Human Genome Project (HGP) in 2003 successfully resulted in 
sequencing the first human genome, which is representative of the complete set of genes 
present in the cell. Initiated by James D. Watson at the National Institutes of Health – USA in 
1990, the goal of the HGP was to determine the precise sequence of base pairs in DNA that 
represented genes within the genome. Furthermore, the focal point of the project was to 
identify an anticipated 25,000 genes pertinent to the human genome from both a physical and 
functional perspective. Although the HGP is now complete from the sequencing standpoint, 
one is left to wonder whether this initiative was just a preparation for a massive biological 
jigsaw puzzle. After all, the resulting sequenced human genome has spawned challenges to 
relate the genomic sequences to specific biological functions in order to better understand 
biological systems and to enhance our comprehension of the underlying dynamics of disease. 
Furthermore, although biological functions have already been allocated to thousands of 
genes, merely knowing their biological roles is not sufficient to warrant an understanding of 
the biological networks that govern cellular behaviour. This is because gene function and 
behaviour is governed by complex molecular interactions and dependencies, which are 
intertwined in a cellular network that determines the overall fate of the cell. For this reason, 
gene function and behaviour needs to be understood in the context of the organism as a single 
1 
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unit, which at the same time, is capable of hosting complex inter-dependent biological 
interactions. 
As means to provide a platform for molecular biologists to further understand the biological 
functions of known genes and discover those of unknown genes, the scientific and research 
communities have embraced a valuable high throughput laboratory based technique called 
microarray technology. Using this technology, molecular biologists can simultaneously 
quantify gene expression levels for thousands of genes or even entire genomes at once for 
any given biological question. Vital to its widespread popularity, microarray technology is 
regarded as a superior technology due to its biological usefulness and high throughput nature. 
Unlike traditional low throughput molecular biology techniques such as southern blotting, 
which are limited to the quantification of gene expression on a gene-by-gene basis, 
microarray technology offers a platform for putative biological discoveries to be made at an 
efficient pace, making it feasible to readily identify the potential involvement of genes in 
several biological processes. Although the benefits of microarray technology cannot be 
denied, it is also undeniable that the technology is not perfect, which is largely due to the 
colossal amounts of data that it generates, attributed to the knowledge Vs data paradox. To 
elaborate, the goal of microarray technology is to speed up the process of quantifying gene 
expression in order to extract meaningful biological knowledge, which paradoxically 
becomes a problem when too much raw data is generated from the use of the technology. 
With vast magnitudes of generated raw biological data, how does one go about mining the 
data to find answers to the original biological question of the experiment? The answer lies in 
bioinformatics. 
Bioinformatics is a fast growing inter-disciplinary science, which applies computer 
technology to biological data in order to manage it. More specifically, it can be defined as a 
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science that integrates informatics, mathematics, computer algorithms and statistics together 
to solve complex biological problems. The application of bioinformatics in the milieu of gene 
expression analysis has attracted a great deal of attention in the recent past due to specific 
algorithms and software solutions that attempt to illustrate complex multidimensional 
microarray data in a biologically coherent fashion so that it can be understood by the 
biologist (Slonim, 2002; Spang, 2003). This has indeed given rise to some exciting prospects 
for deciphering microarray data in order to aid the enhancement of our comprehension 
pertinent to the underlying physiological dynamics of disease.  However, the advent of such 
an approach has also highlighted some important challenges. Perhaps the most notable 
challenge stems from the reality that biological data are disseminated in different 
laboratories, each having different management systems, file formats and methods for 
representing their biological data (Battistella et al, 2005). The heterogeneity of the data poses 
a problem for researchers due to a lack of cohesive vocabulary, which in turn hampers the 
progress of novel biological discoveries. For this reason, the attention is now shifting towards 
biological data integration. 
The premise of this PhD study is based on the design, development and implementation of 
bioinformatics software using a data integration approach, all in the context of systems 
biology. Scrutinizing the relevant scientific literature reveals a soaring need for specialised 
software tools that cater for the high throughput analysis of microarray data in the perspective 
of systems biology. The approach proposed in this study is to integrate data at the DNA 
transcriptional level (transcription factor related data) with protein and molecular pathway 
data under a series of automated pipelines designed to facilitate microarray data analysis 
according to the users’ specific needs. 
1.2  Systems biology 
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The paradigm of systems biology is motivated by the fact that biological sciences is no longer 
a self sufficient discipline because it has become highly reliant on informatics, mathematics, 
computer algorithms, software development and statistics. It is hence no surprise that biology 
has amalgamated with the aforementioned disciplines, giving rise to a new era of 
opportunities for novel biological discoveries. Systems biology is a new research area that 
employs a multidisciplinary approach to look beyond the function of a single gene.  As stated 
by Butcher et al (2004), “The goal of modern systems biology is to understand physiology 
and disease from the level of molecular pathways, regulatory networks, cells, tissues, organs 
and ultimately the whole organism”. It is hence clear that systems biology is a holistic 
approach (Chong and Ray, 2002), which aims to facilitate a systems level understanding of 
biology by integrating knowledge pertaining to various different components that collectively 
determine the overall biology of the organism. This is an effective strategy since it 
encourages a scrutiny of the structure and dynamics of cellular function in the context of the 
organism as a whole rather than examining the characteristics of isolated parts of the cell or 
organism (Kitano, 2002). 
 
With the advent of microarray technology, the focus of biological data interpretation has led 
to a rapid paradigm shift in molecular biology. Because a single microarray experiment 
typically generates several thousands of gene expression data points, it is becoming clear that 
there is great potential for novel biological discoveries provided the data is deciphered in the 
context of systems biology. In order to progress in this endeavour, it is essential to move to 
the systemic picture whilst gaining a deeper understanding at the molecular and biological 
levels (Kitano, 2002). Although systems biology is considered a new research discipline, the 
notion of integrative thinking is not new to molecular biology since the first molecular 
regulatory circuits were mapped out over 40 years ago (Westerhoff, 2004) (Figure 1.1).  
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Figure 1.1 An illustration of how two lines of enquiry led to the birth of present-day systems biology. 
The upper timeline reflects progress in molecular biology over the past years leading to systems 
biology. The lower timeline shows the formal analysis of functional states that arise when several 
molecules interact concurrently. (Taken from Westerhoff, 2004). 
 
The importance of systems biology becomes apparent when we examine the current situation 
with drug discovery. Despite the fact that an astronomical amount of investment has taken 
place over the past 20 years towards screening technologies and genomics, the truth remains 
that the costs associated with new drug discovery continue to rise while approval rates fall. 
This is because the desire to effectively mine the genome has met paths with the realization 
that merely knowing a target is not sufficient to warrant an understanding of what the target 
does, let alone knowing the effects of a chemical inhibitor in diverse disease settings 
(Butcher, 2004). This emphasizes the need for an effective approach to integrate biological 
data in the form of automated pipelines that can be used to facilitate biological predictions in 
the context of high throughput gene expression data analysis.  
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Figure 1.2 The application of systems biology in the pharmaceutical industry. Omics represents a 
bottom-up approach towards the identification of components at the molecular level (molecules and 
pathways). Modelling takes a top-down approach by starting from human physiology and disease. 
(Taken from Butcher, 2004). 
 
The study of Omics plays a central role in systems biology and drug discovery. Omics is a 
specific term used to describe a broad research discipline focusing on the analysis of 
biological interactions that take place within various Omes or biolayers. Omics approaches to 
systems biology have been wholeheartedly accepted by the pharmaceutical industry in order 
to complement traditional approaches to target identification, generate hypotheses and for 
experimental analysis (Butcher, 2004). The strength of Omics lies in its use in generating 
potentially important hypothesis. For instance, it can be used to answer specific biological 
questions pertinent to high throughput experimental studies, which may be conducted in 
order to correlate a given disease state to the expression of specific genes or proteins (Figure 
1.2). This has given rise to some very exciting prospects for treating disease and this is 
precisely the reason why there is a soaring desire for effective computational solutions 
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capable of deciphering colossal amounts of gene expression data in the milieu of systems 
biology.  
 
1.3  Loopholes in existing works and contribution to knowledge 
The current situation is such that there is a great deal of research being conducted in the area 
of systems biology, where several software tools have been generated for the purpose of 
deciphering high throughput gene expression data using a number of different methodologies. 
However, there is much to be desired and several loopholes are yet to be accommodated. The 
intensity of such attempts is motivated by the fact that a paradigm shift has occurred from a 
reductionist approach to an integrative one. As stated by Aggarwal (2003), “The reductionist 
approach to biological research, which has been extremely important to the development of a 
basic understanding of living system, is geared towards identifying the individual components 
(genes, proteins, metabolites etc) responsible for a particular phenomenon in an organism 
(e.g. metabolic activity, response to external stimuli etc). This approach has proven effective 
at elucidating key molecular components of living systems, leading to a variety of important 
applications in agriculture and medicine. It is now clear however, that information at only 
one level (the genome or the proteome, for example) by itself cannot fully explain the 
behaviour of any particular biological system.” In light of this, the field of systems biology is 
facing a great deal of pressure to devise effective integrative strategies to enhance our 
understanding of the physiology of disease states. 
 
In the past, a number of software have been developed for the purpose of automating a 
systems level analysis of microarray data such as Expander (Shamir, 2005), INCLUSive 
(Thijs, 2002), Genesis (Sturn, 2002), CONFAC (Karanam, 2004), and GEPAS (Herrero, 
2003). These pipelines specialise in streamlining the analysis flow by performing specific 
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functions such as K-means clustering, promoter and functional analysis etc. This is no doubt 
an important step towards deciphering high throughput expression data in a systems biology 
context. However, further integrative strategies are required to move forward in this 
endeavour, which should complement a biologically valid understanding of how a cell 
functions as a whole.  
 
It is important to understand that the overall fate of a cell is determined by three principle 
classes of interactions, 1) the binding between genomic DNA and specific DNA-binding 
proteins called transcription factors (TF’s), via regulatory binding sites, 2) participation of 
Protein-protein interactions between two separate protein molecules in the cellular cytoplasm 
and finally, 3) the cascade of molecular and signalling events that dictate the behaviour of a 
given molecular pathway. A detailed explanation of these classes of interactions is provided 
in Chapter 2 of this thesis. There is currently a need for specialised software tools that cater 
for the analysis of microarray data under the integrative framework of the aforementioned 
classes of interactions. This is an important step since the goal of systems biology is to 
understand molecular interactions in the perspective of the organism itself. 
 
Furthermore, because high throughput technologies such as microarrays are rapidly gaining 
popularity at a global scale due to the prospect of efficiently quantifying gene expression in a 
high throughput fashion in order to identify previously unknown transcriptome states, 
expression data related to various different biological questions are being readily generated 
by scientists worldwide. Such data sets are continuously being uploaded to public data 
repositories such as ArrayExpress (Sarkans, 2005) and the Gene Expression Omnibus (GEO) 
(Edgar, 2002), which are subsequently made accessible to the public. This has opened a 
gateway for biologists to utilise these sets of data in an attempt to investigate common 
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regulatory signatures that may be responsible for dictating biological questions sharing a 
similar biological theme. One of the most common methods of comparison is based on the 
assumption that genes across different biological conditions exhibiting similar expression 
patterns are likely to be involved in the same biological process (Barrett, 2006) and may 
therefore, share common regulatory signatures. By using this method of comparison, which is 
one of the most successful methods to date, coupled with the availability of publicly available 
data repositories offering gene expression data, biologists have been granted the opportunity 
to answer complex biological questions with regards to biological phenomena underlying 
various different disease states. When one scrutinizes current literature relevant to automated 
solutions of gene expression analysis, it becomes apparent that there is an increasing demand 
for software applications that offer an efficient pipeline to the analysis of multiple gene 
expression profiles. 
 
In light of this, the research presented in this thesis is based on the following contributions to 
knowledge: 
 Identification of existing loopholes in systems biology from a software development 
perspective 
 Design, development and implementation of a bioinformatics software tool 
specializing in deciphering gene expression data at the transcriptional level, using 
Position Frequency Matrices (PFM’s) 
 Design, development and implementation of a bioinformatics software pipeline to 
facilitate the automation of gene expression analysis in the context of transcription 
factors, protein-protein interactions and molecular pathway analyses 
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 Further development of a novel bioinformatics software pipeline to incorporate the 
analysis of multiple gene expression profiles in order to identify common regulatory 
signatures 
 Proposition of a novel blueprint for future prospects of treating disease 
 
1.4  Roadmap  
In this section, the structure of the thesis is described together with a brief summary of what 
each chapter comprises of. 
 
Chapter 2 is concerned with providing a review of microarray technology covering aspects 
such as laboratory procedures, raw data generation, differential gene analysis etc. Prior to 
this, the three principal classes of molecular interactions are explained, which involves the 
science behind how transcription factors interact with genomic DNA, how proteins interact 
with one another in the cytoplasm and how molecular pathways are regulated in order to 
collectively govern overall cellular behaviour. Finally, current literature pertaining to the 
subject of bioinformatics software for microarray data analysis is scrutinized to act as the 
premise for the subsequent chapters. 
 
Chapter 3 presents a bioinformatics software called BiSAn, which has been specifically 
designed, developed and implemented for high throughput gene expression analysis by using 
Position Frequency Matrices (PFMs) to scan promoter sites for the presence of Transcription 
Factor Binding Motifs (TFBMs). This work represents the first contribution of this PhD 
study. 
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Chapter 4 introduces an integrative strategy to microarray data analysis in the form of a 
software pipeline called Genome Interactions Analyzer (GIA), which deciphers gene 
expression data in the context of transcription factor binding sites, protein-protein interactions 
and molecular pathways.   
 
Chapter 5 highlights an important loophole in the area of systems biology by emphasizing on 
the necessity to analyze biologically related multiple gene expression profiles, which is an 
essential requirement for better understanding the physiology of disease. The contribution 
presented in this chapter takes the form of a novel algorithm and software pipeline, developed 
to facilitate multiple analyses of gene expression data in a user friendly and automated 
manner. Relevant statistical tests are also applied and the pipeline’s faculty to demonstrate 
multiple gene expression analysis from the perspective of pathway analysis is presented. 
 
Chapter 6 concludes this thesis by offering a rationale for effectively treating disease, from 
the perspective of in silico studies to in vivo laboratory experiments. 
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Chapter 2 
Background 
 
2.1 Introduction 
Systems biology is a newly established multi-disciplinary science, which integrates Computer 
Science, Mathematics, Informatics, and Statistics in order to offer a holistic approach to 
facilitate a systems level understanding of biology by understanding physiology and disease 
from the level of molecular pathways, regulatory networks, cells, tissues, organs and 
ultimately the whole organism (Chong and Ray, 2002; Butcher, 2004). The premise of the 
research presented in this thesis is based on the development of specialized bioinformatics 
software in the context of systems biology. As this area is constantly evolving, a single 
definition does not suffice when attempting to specify its objectives in their entirety. Hence, 
the purpose of this chapter is to provide the reader with a systematic walkthrough of specific 
biological principles that form the backbone of systems biology, which are imperative to 
warrant an understanding of the contributions presented in this thesis. Firstly, the reader is 
provided with an explanation of DNA and the paradigm of gene expression. Next, the three 
principle classes of molecular interactions that collectively govern overall cellular behaviour 
is described followed by an overview of microarray technology. Finally, literature pertinent 
to microarray data analysis from the perspective of computational biology and bioinformatics 
is scrutinized to summarize the work that has been carried out till present day. 
 
 
 
 
2 
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2.2 Explanation of biological terms 
2.2.1 DNA 
Deoxyribonucleic Acid or DNA is the genetic blueprint of life that contains precise 
instructions that dictate the structure and functions of cells. Abundantly located in the nucleus 
of the cell, DNA exists as a hereditary code comprising of four specific chemical bases 
namely, Adenine (A), Guanine (G), Thymine (T) and Cytosine (C). In humans, the total DNA 
within the nucleus of the cell consists of approximately 3 million of these bases and it is the 
order or the sequence of these bases that governs the accuracy of the information available 
for cell structure and function. To understand the importance of the precise sequence of DNA 
in controlling cell behaviour, consider a scenario where you are giving someone instructions 
in English to perform any given task. The precise sequence of letters from the English 
alphabet used to construct words will determine the clarity of the instructions. Similarly, the 
sequence of bases in DNA determines the accuracy of the instructions.  
 
Almost every cell of a living organism contains the exact same DNA so why do cells behave 
differently to one another? This is because only a proportion of the overall DNA in a given 
cell is “expressed” (Refer to section 2.2.2 below for a review of gene expression) and the 
precise location and length of the sequence coding for a specific protein (genes) varies from 
cell to cell. Genes that are expressed in skin cells for instance may not all be expressed in 
other cell types although almost all cells contain the exact same DNA. First postulated in 
1958 and subsequently published in 1970 (Crick, 1970) the central dogma of biology 
illustrates how information contained in DNA is used to synthesize polypeptides (primary 
structure of proteins) via the process of transcription and translation (Figure 2.1). 
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Figure 2.1 The central dogma of biology illustrating how information coded within DNA is 
transcribed into RNA via the process of transcription and subsequently translated into protein via 
translation. (Image constructed in Microsoft Word). 
 
The central dogma of biology postulates that “information cannot be transferred back from 
protein to either protein or nucleic acid. For proteins to be synthesized, DNA acts as a 
template for messenger RNA (mRNA) synthesis via the process of transcription. This is 
necessary since DNA is located in the nucleus and is bound there. The newly synthesized 
mRNA then exits the nucleus and travels to the ribosomes located in the cytoplasm of the 
cell, where the information contained within mRNA is used to dictate the assembly of amino 
acids into polypeptides during the process of translation. The production of protein from 
DNA is therefore, an indirect process mediated by mRNA synthesis and the coding 
information cannot be transferred from protein to any other molecule (i.e. protein, RNA, or 
DNA), although the reverse holds true.  
 
 
DNA 
1. Replication 
2.  Transcription 
RNA 
3. Translation 
Protein 
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2.2.2 Gene expression 
Gene expression is a term exclusively used to describe the process by which coding 
information within a gene leads to the production of a protein specific to that gene. Because a 
gene is a specific length of DNA coding for one or more polypeptides, it can be said that the 
gene is “expressed” when it leads to the synthesis of polypeptides that it codes for via the 
processes of transcription and translation. In other words, gene expression is the end result of 
translation and post-translational modifications. The relationship of genes and proteins is 
important in accurately understanding gene expression. Genes exist in the form of DNA 
sequences in the nucleus of the cell, which are programmed to synthesize proteins. Proteins 
on the other hand, are the product of genes and it is proteins that directly implicate cell 
behaviour by regulating various different cellular processes. Gene expression is hence, the 
production of one or more proteins as dictated by a given gene (Figure 2.2). 
 
The fact that the human genome is being successfully sequenced has given birth to the goal of 
identifying all protein coding genes. However, in order to understand their functions in 
different physiological contexts, it is imperative to understand how their expression is 
regulated (Mintseris, 2006). In addition, gene expression is regulated by a number of different 
factors such as genes themselves, their products and even the products product (Stryer et al., 
2006). To aid in this, several high throughput techniques are available to efficiently facilitate 
the quantification of gene expression, most notable being Microarray technology (Schena et 
al., 1996). This is discussed in more detail in section 2.3 of this thesis. 
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Figure 2.2 The complete process of gene expression involving transcription of DNA into mRNA, 
transport of mRNA into cytoplasm where it interacts with ribosomes to facilitate translation, and 
participation of tRNA (transfer RNA) in the synthesis of amino acid chains (proteins). Image taken 
from http://www.genome.gov 
 
2.2.3 Transcription Factors 
 
Transcription Factors (sometimes called sequence-specific DNA binding factors) are 
specialized proteins that bind to specific DNA sequences (called transcription factor binding 
sites) thereby regulating transcription (Latchman, 1997). These DNA-binding proteins can act 
alone or they can form a complex with other protein molecules and they control transcription 
by activating or suppressing the recruitment of RNA polymerase. Since RNA polymerase is 
  
32 
 
an enzyme that controls transcription of DNA to mRNA in the nucleus of the cell, it is not 
surprising that transcription factors are able to impact gene expression to such a level. A 
prominent characteristic of transcription factors is that they contain one or more binding 
domains, which attach to their respective transcription factor binding sites adjacent to the 
genes that they regulate (Mitchell, 1989., Ptashne, 1997) and the binding occurs on either the 
promoter or enhancer sites of the genome. It has been estimated that there are approximately 
2600 proteins that contain DNA binding domains in the human genome and a majority of 
these proteins are assumed to function as transcription factors (Babu, 2004).  
 
The faculty of transcription factors to interact with DNA sequences in the genome to control 
transcription and ultimately the amount of gene expression has spawned a great deal of 
interest among researchers. This has motivated them to carefully examine promoter regions 
of genes to identify the involvement of certain transcription factors in the regulation of the 
genes (Kel, 2006). In the context of high throughput gene expression analysis such as 
microarrays, it is becoming common practice to employ this methodology to help answer 
complex biological questions since such technology allows biologists to efficiently quantify 
mRNA transcript levels for thousands of genes or even entire genomes concurrently. The 
application of promoter analysis to identify putative transcription factor binding sites in the 
perspective of whole genome analysis has hence, gained widespread popularity. 
   
2.2.4 Protein-protein interactions 
Once proteins have been synthesized by DNA via transcription and translation, they 
participate in regulating cellular behaviour in several different ways. An important trait of 
proteins is their ability to interact with other proteins to regulate many biological functions. 
For instance, protein-protein interactions play a fundamental role in signal transduction by 
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mediating signals from the exterior of the cell to the inside of the cell. Sometimes a protein 
may form a complex with another protein in order to carry the protein it binds to from the 
cytoplasm to the nucleus and vice versa. Others may participate in protein-protein 
interactions to modify the structure of a protein, which may in turn alter the function of that 
protein. In any event, these interactive capabilities of proteins are vital to many biological 
processes that occur within the cell and it is crucial to gain a better understanding of them in 
order to enhance our comprehension of the underlying dynamics of disease. For example, 
signal transduction plays a major role in many diseases including Cancer and since proteins 
mediate signal transduction via protein-protein interactions, it becomes of utmost priority to 
study them in more detail.  
 
There are a number of laboratory based methods commonly used to detect protein-protein 
interactions, such as Bimolecular Fluorescence Complementation (BiFC) (Lu et al., 2008), 
Co-Immunoprecipitation and Fluorescence Resonance Energy Transfer (FRET) to name a 
few. 
 
2.2.5 Molecular Pathways 
In order to maintain the biological processes of life, cells must have a well orchestrated 
cascade of events that allow them to function properly. Molecular pathways form the cellular 
machinery that precisely regulates cell function by organizing proteins and inorganic 
molecules so that they can participate in various mechanisms central to the sustenance of the 
cell. Proteins together with their substrates are typically involved in highly complex 
interconnected chain of events and collectively, they constitute what is known as a molecular 
pathway. Because a cell hosts a vast number of biological processes and mechanisms, there 
are generally several active molecular pathways for a given cell. These pathways tend to 
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work together to ensure that the organism continuously responds to changes in the internal 
and external stimuli. 
 
However, sometimes the normal behaviour of pathways is affected as a result of mutations, 
leading to the production of oncogenes. For instance, the cell cycle pathway is vital to the 
normal functioning of a cell because it controls cell proliferation (Figure 2.3). On the other 
hand, cancer is a disease which results from uncontrolled cell proliferation and hence, the 
relationship between cell cycle and cancer is undeniable. The proliferative capability of 
cancer cells leads to an excess of cell number, which is a consequence of a reduction in 
sensitivity to signals that normally tell a cell to adhere, differentiate or die (Collins, 1997). 
Because cell proliferation is expected in a healthy cell, it becomes problematic to identify the 
exact causality of uncontrolled proliferation attributed to cancer. Similarly, the 
overproduction of a specific signalling protein called Epidermal Growth Factor receptor 
(EGF) has been implicated in many breast cancers because this overproduction has been 
known to cause uncontrolled cell division, leading to the development of tumours (Weinstein 
et al., 1997).  
 
From a systems biology point of view, the study of molecular pathways is vital if we are to 
improve our understanding of various different states of disease due to the fact that when a 
disease occurs, several key molecular pathways may be affected negatively. Gene expression 
studies from the use of microarrays has made it possible for us to correlate gene expression in 
a given disease phenotype to the affected area of several key pathways, hence providing us 
with the opportunity to decipher gene expression in a systems biology context. It is therefore, 
not surprising that a common challenge faced by all researchers is to translate gene 
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expression data points into a better understanding of the underlying biological phenomena by 
putting this in the context of the whole organism as a complex system (Dragichi et al., 2007). 
A study of biochemical pathways in particular is an important focal point in drug discovery 
and it is widely accepted as an important strategy by many biopharmaceutical and genomic 
companies (Dhillon et al., 2007). 
 
Figure 2.3 The cell cycle pathway illustrating how the complexity of molecular interactions and 
collaboration with other pathways results in controlled cell proliferation. Image taken from 
http://www.genome.jp 
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2.3 Microarray Technology 
The history of microarray technology dates back to the 1980’s, when it evolved from a well 
established laboratory technique called southing blotting (Southern et al., 1999)  used to 
attach a fragmented DNA to a substrate followed by probing it with a known target gene. It 
was not until 1987 when a collection of DNA sequences were used in arrays for the purpose 
of expression profiling (Kulesh et al., 1987).  
 
Microarray technology has revolutionized the field of molecular biology by offering an 
efficient and cost effective platform for the simultaneous quantification of thousands of genes 
or even entire genomes in a single experiment. Unlike southern blotting, which is restricted to 
the measurement of one gene at-a-time, microarrays offer biologists with the opportunity to 
carry out genome-wide experiments in order to help them gain a systems level understanding 
of cell regulation and control. Central to the technology, microarrays are a major 
breakthrough due to the use of a DNA chip (made of glass, plastic or silicon biochip) on 
which specific sequences of DNA (or entire genomes) are robotically printed using a 
microarrayer. Labelled DNA or RNA samples are then applied to the chip in order to detect 
complementary sequences.  A typical gene expression profiling experiment is motivated by a 
specific biological question asked by the investigator. Expression levels of thousands of 
genes are then simultaneously monitored in order to study the effects of certain biological 
conditions, disease types and treatments on gene expression (Adomas et al., 2008). 
 
2.3.1 The Microarray Procedure 
The high throughput nature of microarray technology makes it a fundamental asset to the 
field of molecular biology because it circumvents the restrictions set by one-gene-by-one-
experiments (i.e. Southern blotting) as before (Schena et al., 1995; 1996). With the advent of 
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this technological breakthrough, several thousands of genes can be scrutinized concurrently 
in a single experiment (Spellman et al., 1998), making it possible to observe a global 
snapshot of the entire cell in a specific time point and/or following a particular treatment.  
 
DNA microarrays are constructed by attaching fragments of DNA (each representing a 
specific gene at its known position) such as library clones or PCR (Polymerase Chain 
Reaction) products to a solid substrate (Schena et al., 1995). A robotic microarrayer is used to 
print the fragments on to the substrate, which can typically spot more than 20,000 fragments 
per substrate. RNA is then extracted from the untreated cell sample (control) and treated 
sample (test), which are then each reverse transcribed into cDNA. During reverse 
transcription, as each cDNA sample is being synthesized from the RNA template by the 
enzyme Reverse Transcriptase (RT), they are each labelled with a specific fluorescent dye 
(Cy3 and Cy5 for the control and test samples respectively), which becomes incorporated into 
the newly synthesized cDNA. Following the synthesis of labelled cDNA, equal amounts of 
each cDNA sample (test and control) are combined and subsequently hybridized on to the 
microarray chip (containing DNA fragments of known genes). By labelling both samples 
with different fluorescent dyes (Cy3 and Cy5), relative abundance of mRNA transcript levels 
can be measured by determining the fluorescence ratio for each spot on the substrate when 
scanned. Figure 2.4 illustrates the complete microarray process. 
 
  
38 
 
 
Figure 2.4 DNA microarrays. DNA fragments are spotted on to a glass slide (top right). RNA is then 
extracted from the two samples to be compared and then fluorescently labelled cDNA is prepared by 
reverse transcription, leading to the incorporation of Cy3 dye (green) in the control cDNA sample and 
Cy5 dye (red) in the test cDNA sample (top left). Both labelled cDNA samples are then mixed and 
hybridized on to the microarray and the slide is scanned to generate the image. In the image, green 
spots reflect down-regulated (under expressed) genes, red represent up-regulated (over expressed) 
genes and yellow show an equal expression of both red and green. Special image analysis software is 
used to determine signal intensities for each dye at each array position and logarithm of the ratio of 
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Cy5 intensity to Cy3 is calculated to determine the strength of expression. Once intensity ratios are 
calculated for each array position, positive Cy5/Cy3 ratios indicate over expressed genes and negative 
Cy5/Cy3 ratios indicate under expressed genes. The datasets can then be analyzed by cluster analysis 
(bottom). (Image taken from Cummings & Relman, 2000). 
 
2.3.2 Pre-processing microarray data & differential expression analysis 
Underlying every microarray experiment is a specific biological question being addressed 
and in order to effectively answer the biological question, intensity ratios of all genes on the 
microarray chip must be carefully examined to accurately identify those genes that exhibit a 
significant difference of expression between the test and control samples. By narrowing down 
the genes of interest, the focus of data interpretation becomes concentrated on these 
potentially meaningful genes, hence providing the biologist with clues as to where the answer 
to the biological question may lie. Furthermore, because microarray experiments typically 
generate colossal amounts of raw biological data, inconsistencies may arise in the gene 
expression measurements due to sources of non-experimental variations. Preprocessing 
microarray data, including image analysis, normalization and data transformation is an active 
research area and how to suitably quantify spots on microarrays remains a topic of great 
enquiry (Allison et al., 2006). 
 
Because gene expression measurements are derived from the microarray image itself (when 
the microarray chip is scanned and subsequently generated on screen by specialized analysis 
software tools), a great deal of attention is dedicated to effectively process microarray images 
and many image processing approaches have been developed in the past to cater for this need 
(Chen et al., 1997; Schadt, et al., 2001; Ekstrom et al., 2004; Yang et al., 2001; Steinfath et 
al., 2001). An important preprocessing step is normalization, which allows comparisons to be 
made between microarray experiments by controlling extraneous variation among 
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experimental datasets (Allison et al., 2006). Normalization is carried out by applying 
statistical methods to the entire experimental datasets (Lee et al., 2000) so that gene 
expression comparisons can be made in a manner that minimizes systematic bias. Gene 
expression measurements are derived from measuring the distribution of pixels in each spot 
on the microarray image and the intensity of pixilation of each spot can be used to assess the 
degree of similarity of the distribution in relation to the normal distribution. Researchers can 
also manually flag groups of spots or individual spots as good, bad or absent in order to help 
them differentiate between valid and invalid measurements of expression. Other statistical 
methods such as Standard Deviation (SD) can also be used to observe the spread of the entire 
data. The purpose of these statistics is to act as an aid for researchers by allowing them to 
estimate which spots are statistically usable so that they can be incorporated into the final 
dataset (Dudoit et al., 2002).  
 
Pre-processing and normalizing microarray data with the purpose of minimizing the effects of 
systematic error while retaining full biological variation are critically important goals that 
need to be given consideration if valid results are to be obtained from the experiment 
(Zahurak et al., 2007). During the normalization process, the dual dye measurements of each 
spot are used as a basis to estimate the relative abundance of expression for each gene by 
comparing the colour intensity of the test dye (Cy5) relative to the control (Cy3) at each spot 
on the array. The measurements are Log transformed (Logarithm to the base of 2) and from 
the resulting values over and under expressed genes can be readily identified, since positive 
values represent genes that are over expressed in the first condition compared to the second 
and negative values represent genes that are under expressed in the first condition compared 
to the second (Dudoit et al., 2002). Fold change is one of the most widely used approaches 
employed for the purpose of comparing the expression levels of genes across different 
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biological conditions. Consider two biological conditions, X and Y, where each expression 
value of each gene has been log transformed. Fold change is calculated simply by subtracting 
each gene expression value of the biological condition exhibiting a lower expression 
measurement from the condition exhibiting a higher gene expression value. In other words, if 
X > Y, then X – Y, else Y – X.  The result of this is that positive fold change values will 
indicate genes that are over expressed in biological condition X in comparison to Y, while 
negative values will indicate under expressed genes in condition X compared to Y. A fold 
change threshold is used to define the extent of biological variation that is considered to be 
significant by the researcher performing the experiment, which generates a narrowed down 
set of genes considered to be highly significant in answering the biological question. These 
genes of interest are referred to as differentially expressed genes. 
 
The fold change approach was the first method used to assess whether genes are differentially 
expressed by adequately measuring effect size and its popularity predominantly stems from 
its simplicity (Allison et al., 2006). However, fold change calculations should not be used as 
a sole basis to measure biological variation primarily because it is widely considered to be an 
inadequate test statistic (Hsiao et al., 2004; Miller et al., 2001). This is because it does not 
offer an associated level of confidence and hence, it fails to incorporate variance (Hsiao et al., 
2004; Budhraja et al., 2003). This is not to say that the fold change approach should not be 
used because it is conceptually useful due to the fact that it assumes a constant variance 
across transcripts (Allison et al., 2006). Nevertheless, if valid biological inferences are to be 
made, its use should be coupled with other test statistics such as the T test statistic.  
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2.3.3 Clustering gene expression data 
High throughput experiments such as microarrays no doubt generate vast amounts of 
biological data, which is not surprising considering the fact that they are designed to 
simultaneously quantify thousands of genes. In other words, the voluminous nature of the 
output is directly proportional to the volume of genes on the microarray chip (the input). For 
this reason, making valid biological inferences from the generated data can be a daunting task 
for the common biologist. An important objective of a microarray experiment is to identify 
groups of genes that exhibit similar behaviour of expression, since this is indicative that they 
may share common regulatory signatures and may ultimately be involved in the same 
biological processes (Barrett et al., 2006). This objective is fundamentally important because 
it has the potential to help answer the specific biological question motivating the microarray 
experiment. One of the most common methods of analyzing expression data in this context is 
clustering (Hand & Heard, 2005).   
 
Clustering is a very effective technique to extract interesting patterns of gene expression 
across different biological conditions, whilst circumventing the problematic nature of 
expression data attributable to the complexity of biological networks that lie hidden within 
the data. The simplest explanation of clustering is based on the paradigm of grouping subsets 
of genes (into clusters) that show similar expression measurements so that interesting 
biological patterns can be easily visualized. However, in order to take maximum benefit from 
the use of clustering, care must be taken to ensure that trivial subsets of genes are not 
included in the clustering analysis while employing the more interesting ones. When 
performing any sort of clustering, the distance metric is used to define the measure of 
similarity, which is a function that uses two points in a dimensional space where symmetry 
lies (Shay, 2003). There is not a single clustering solution universally applicable to all 
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biological problems and several different clustering algorithms have been developed, each 
suitable for specific needs (Everitt, 1980). Some examples include Hierarchical clustering 
(Eisen et al., 1998; Heyer et al., 1999; Qin et al., 2003), Self Organizing Maps (SOMS) 
(Ressom et al., 2003; Kohonen, 1995), K-means clustering (Tavazoie et al., 1999), and 
Principal Component Analysis (PCA). Since Hierarchical clustering and K-means clustering 
are most widely applicable to the analysis of gene expression data, they ought to be discussed 
here in some detail. 
 
2.3.3.1 Hierarchical Clustering 
Hierarchical clustering (Eisen et al., 1998) is usually the first clustering method of choice 
when analyzing gene expression data. The method itself is based on a single layered neural 
network and when performed, it hierarchically groups genes located near each other and with 
similar expression patterns together across a series of samples. The algorithm computes 
distance relationships between genes and experiments in a pair-wise manner and joins pairs 
of expression values that are most similar in expression to form what is called, a node. Upon 
each iteration, clusters of genes with similar expression patterns are then merged together into 
a single cluster until the desired number of clusters is obtained (Figure 2.5). The hierarchical 
arrangement of clusters takes the form of a dendrogram, which is a classical tree structure 
that appears when the clusters are graphically represented (Hand & Heard, 2005). The 
dendrogram illustrates the relationship between the clusters, making it easy to visualize 
different segments of similarly expressed genes.  
 
Although Hierarchical clustering is one of the most common clustering approaches used 
widely for the analysis of gene expression data, there are some limitations of its use. Firstly, 
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it fails to yield meaningful results as the number and size of datasets to compare grow. It is 
also notorious for not being very robust.  
 
 
 
Figure 2.5 Hierarchical clustering. The dendrogram on the top represents the relationships between 
clusters of genes and the dendrogram on the left illustrates the relationships between the experimental 
conditions. Clusters of similarly expressed genes are grouped together, where red represents over-
expressed genes, green represents under-expressed genes and black represents no change in 
expression. Image taken from Auman et al., 2007. 
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2.3.3.2 K-means Clustering 
K-means (Tavazoie et al., 1999) is a straight forward and efficient clustering method that 
arbitrarily divides the entire dataset into k number of disjoint subsets (Figure 2.6). The 
criterion used to define the number of clusters to divide the data into is user-defined and so as 
soon as the user inputs the number of clusters that they intend the data to be divided into (k), 
k-means efficiently segregates the dataset into k number of partitions, the centre of each 
partition or cluster being called a centroid. The k-means algorithm groups data in an optimal 
manner by calculating the distance between each gene and the centroid of each cluster. This 
ensures that each gene is assigned to the centroid (and subsequently grouped into that cluster) 
with the closest Euclidean distance whilst ensuring maximal distance between genes 
belonging to different clusters.  
 
The main drawback of k-means clustering is its arbitrary nature of clustering data, which 
generates different results each time it is performed. This is because the algorithm assumes 
no knowledge of the number of clusters in a given gene expression dataset, resulting in an 
alteration of results after each successive run.  
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Figure 2.6 A graphical representation of results generated from a typical K-means clustering analysis. 
In this example, the entire expression dataset is divided into 12 clusters, each consisting of genes 
grouped together showing their expression levels across different time points. The magenta line 
represents the mean expression level of each cluster. Image taken from Kulterer et al., 2007. 
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2.4 Analyzing microarray data in a systems biology context 
With the advent of bioinformatics, a whole new generation of opportunities to decipher 
complex biological data have come into existence. This is especially true in the case of 
microarrays. Since the use of this valuable high throughput technology compels biologists to 
be faced with vast magnitudes of raw complex biological data, bioinformatics has opened up 
a gateway for exciting opportunities in the context of systems biology. We are no longer 
living in an era where the field of biological sciences is self sufficient. Testament to this is the 
fact that the field of biology has become heavily reliant on informatics, mathematics, 
computer algorithms, software development and statistics in order to solve biological 
problems. In the midst of this interdisciplinary matrix, a realization has been born from 
which, the field of systems biology has emerged. It is becoming abundantly apparent that a 
scrutiny of characteristics of isolated parts of the cell or organism is not sufficient to warrant 
a global understanding of how a given organism functions as a whole unit (Kitano, 2002). 
The motivation of systems biology is hence, to understand physiology and disease from the 
integrative perspective of molecular pathways, regulatory networks, cells, tissues, organs, and 
ultimately the whole organism (Butcher et al., 2004). 
 
The marriage of systems biology with microarrays is undeniable. On one hand we have a 
high throughput technology offering a platform to measure mRNA transcript levels for entire 
genomes simultaneously in a cost effective and efficient fashion, and on the other hand, we 
have a interdisciplinary science specializing in the application of mathematics, computer 
science and biology with the fundamental purpose of unravelling the underlying functional 
dynamics of the cell in the perspective of the entire organism. In theory, the possibilities are 
endless. In practice, systems biology is still at its infancy and consequently, there is much to 
be desired. 
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Nevertheless, research in the area of systems biology is intense. There are generally three 
main areas that are progressing steadily. The first is the analysis of high throughput data such 
as microarrays using statistical algorithms and compiling reference databases encompassing 
information pertaining to genes, proteins, enzymes, and entire genomes (Moore, 2007). The 
second is the development of specialized bioinformatics software pipelines to automate gene 
expression analysis in the context of systems biology, and the third is the implementation of 
computational approaches to help answer biological questions. For instance, artificial 
intelligence in the form of neural networks is constantly being applied for pattern recognition 
purposes (Statnikov et al., 2005). Although the intensity of such efforts is undeniable, the 
truth remains that biologists are generally reluctant to employ bioinformatics 
applications/tools, especially if they are not able to comprehend how the analysis is carried 
out (Kulyk & Wassink, 2006). This is acting as a rate limiting factor and with time it is 
becoming more apparent that in order for novel biological discoveries to be made, true 
collaboration must exist between biologists and bioinformaticians. It is also becoming 
apparent that bioinformatics software programs need to be developed in a way in which 
biologists can use them without having problems understanding how the underlying analysis 
is carried out. This is an important step required to reinforce this necessary collaboration. 
 
The current predicament is such that there is a variety of biological data scattered 
everywhere. Several databases are available, each storing crucial biological knowledge. 
Furthermore, much work is being conducted in the field of systems biology by developing 
software applications to facilitate high throughput analysis. The aforementioned situation 
shall be considered in the sections that follow. 
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2.4.1 Transcription Factor databases 
The faculty of transcription factors to interact with DNA sequences in the genome to control 
transcription and ultimately the amount of gene expression has spawned a great deal of 
interest among researchers. This has motivated them to carefully examine promoter regions 
of genes to identify the involvement of certain transcription factors in the regulation of the 
genes (Kel, 2006). Because these regulatory DNA sequences bind to transcription factors in 
order to control transcription and ultimately gene expression, a great deal of effort is being 
placed on understanding these sequences. Attention is now shifting towards representing 
these sequences (called transcription factor binding motifs or TFBMs) in the form of Position 
Frequency Matrices (PFMs) and Position Weight Matrices (PWMs). A detailed explanation 
of these terminologies is explained in the subsequent chapter of this thesis. 
 
Currently, there are publicly available transcription factor databases, such as JASPAR 
(Sandelin, et al., 2004) and TRANSFAC (Matys et al., 2003). JASPAR catalogues matrix-
based transcription factor binding profiles for the purpose of warehousing non redundant 
representations of high quality transcription factor binding site (TFBS) profiles (Sandelin, et 
al., 2004) (Figure 2.7).  The profiles are derived as a result of collecting experimentally 
verified TFBMs (for multicellular eukaryotes) from published data, where some of the 
binding sites were determined by SELEX experiments (Pollock et al., 1990). Such databases 
have given rise to opportunities to analyze these crucial regulatory sequences against 
promoter regions of genes in a high throughput context. 
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Figure 2.7 The User Interface of the JASPAR database, showing the results from a typical query. 
Taken from Sandelin, et al., 2004 
 
2.4.2 Molecular pathway databases 
There are a number of publicly available databases that store information relevant to 
biological pathways and genes. The most prominent pathway database is the KEGG database 
(Kanehisa & Ogata et al., 1999) since it contains a comprehensive collection of known 
biochemical pathways, providing information pertinent to genes and their relationships in the 
pathway networks (Figure 2.8). Furthermore, each pathway is represented as a seemingly 
static pathway map where each member or genes in a given pathway are hyperlinked to the 
underlying comprehensive gene database. Biocarta (http://www.biocarta.com) is another 
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online database, containing a collection of biological pathways. MetaCyc (Karp et al., 2002) 
is a more specialized and specific pathway database, which primarily focuses on the 
dissemination of metabolic pathways. The advantage of MetaCyc is that unlike KEGG, which 
does not allow users to carry out pathway engineering due to a lack of interactive functions, 
MetaCyc facilitates the use of metabolic engineering by offering the capability to interact 
with the pathways in order to add, remove or replace genes. Both KEGG and MetaCyc have 
an active Application Programming Interface (API), giving rise to the opportunity to 
dynamically interact with them by writing code for specific needs.  
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Figure 2.8 The Metabolic Atlas of KEGG, displaying proteins in the form of nodes, and associations 
as lines. Each coloured box represents a separate metabolic pathway and the atlas shows how 
pathways and proteins are interconnected. Taken from http://www.genome.jp/kegg/atlas 
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2.4.3 Available software 
In an attempt to decipher gene expression data in a systems biology context, several 
bioinformatics software tools have been developed. Some examples of such software include 
Expander (Shamir et al., 2005), INCLUSive (Thijs et al., 2002), Genesis (Sturn et al., 2002), 
CONFAC (Karanam et al., 2004) and GEPAS (Herrero et al., 2003). Most of these software 
focus on streamlining the analysis flow of microarray data analysis by implementing specific 
functions such as k-means clustering, bi-clustering, promoter analysis to identify transcription 
factor binding sites and functional analysis. In addition, there are various software 
applications that attempt to extract a systems level understanding by facilitating data analysis 
from the perspective of molecular pathways. Pathfinder (Goesmann et al., 2002) is one of 
such tools, which facilitates pathway engineering from annotated data. GenMAPP 
(Salomonis et al., 2007) is another software relevant to pathway analysis, which is more 
specific for the analysis of microarray data. From the perspective of transcription factor 
analysis, several programs such as MATCH (Kel et al., 2003) and P-MATCH (Chekmenev et 
al., 2005) from TRANSFAC (Matys et al., 2006), PRODORIC (Muench et al., 2003), and 
PoSSuMsearch (Beckstette et al., 2006) are available that can scan upstream sequences of 
putative target genes to identify TFBMs. All of these software and others alike are no doubt 
important in the milieu of systems biology. However, there are several loopholes that are yet 
to be accommodated, some of which are addressed in the subsequent chapters of this thesis. 
 
2.5 Conclusion 
The purpose of this chapter was to provide the reader with a systematic walkthrough of the 
main principles that collectively form the backbone of systems biology. Because the 
relationship between systems biology and microarray technology is a fundamentally 
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important one, an overview of microarray technology was given from the microarray 
paradigm itself to the need for clustering solutions to solve biological problems. Finally, 
current works in the area of systems biology was summarized in order to give an idea of how 
much progress has been made in the field and the array of opportunities available for the 
future. The subsequent chapters of this thesis will now present contributions made during the 
course of pursuing this PhD. 
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Chapter 3 
BiSAn: A software for efficient computation 
of transcription factor binding motifs for high 
throughput gene expression analysis 
 
3.1 Introduction 
DNA-binding transcription factors (TF’s) are important determinants of transcriptional 
regulation and control that bind to specific recognition sites of operator sequences of target 
genes to activate or suppress transcription. Environmental factors coupled with the internal 
conditions of the organism determine the proportion of the complete set of transcription 
factors that are active at a given point in time, making it possible to observe specific states of 
the transcriptome. Although each cell of an organism contains an exact copy of its genome, 
the expression of genes can vary due to different biological conditions, giving rise to different 
transcriptome states. Furthermore, some transcription factors may only dictate the expression 
of a single gene, whereas others may organize the activation or suppression of several genes 
at once (Teichmann et al., 2004). It is this precise molecular ability of TFs to interact with 
specific recognition sites called transcription factor binding motifs (TFBMs) that makes it 
possible for cells to control reproduction, growth and death. It is hence no surprise that a lot 
of attention has shifted towards better understanding these powerful DNA-binding proteins 
together with their target TFBMs. These binding motifs are usually represented as matrices 
and are referred to as position weight matrices (PWMs), position frequency matrices (PFMs) 
or alignment matrices in the scientific literature. 
 
3 
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Position frequency matrices (PFMs) represent the most widely employed model for TFBMs 
and have been catalogued in web-based databases such as JASPAR (Sandelin, et al., 2004), 
where each matrix consists of nucleotide counts per position for a given TF (Stormo et al., 
1982). Given a set of TFBMs, regulatory networks can be predicted through in silico methods 
by using cognate binding sequences to construct models. Using a given PFM pertinent to a 
given collection of TFBMs, consensus binding sites specific to a particular TF can be readily 
derived that represent evolutionarily conserved regions. Scanning such putative binding sites 
in promoter regions of genes has been recognised as an important step in determining the 
potential binding affinity of a transcription factor to its respective binding site(s) and several 
programs such as MATCH (Kel et al., 2003) and P-MATCH (Chekmenev et al., 2005) from 
TRANSFAC (Matys et al., 2006), PRODORIC (Muench et al., 2003), and PoSSuMsearch 
(Beckstette et al., 2006) are available that can scan upstream sequences of putative target 
genes to identify TFBMs. However, careful scrutiny of current literature reveals a growing 
demand for automating this search strategy for the analysis of high throughput expression 
data such as microarrays. Although the aforementioned programs can be used to automate 
high throughput search, it is apparent that there is a lack of available pipelines specifically 
designed for the common biologist who may wish to put a set of differentially expressed 
genes into an automated pipeline in order to scan promoter sequences pertinent to these genes 
for the presence of TFBMs (using PFMs) at the click of a button. 
 
This chapter introduces BiSAn, a software pipeline specifically designed for microarray data 
analysis that uses PFMs to scan promoter sites for the presence of TFBMs enriched in the 
user’s set of data. Regardless of the biological question, a microarray experiment usually 
results in one or more sets of differentially expressed genes, which represent genes that have 
significant difference in expression ratios between the control and test samples. An important 
  
57 
 
challenge is to decipher these expression data points in the context of transcriptional 
regulation to better understand the biological phenomenon under investigation. Once a set of 
differentially expressed genes has been imported by the biologist, BiSAn automatically 
fetches their promoter sequences and subsequently scans them for TFBMs in an efficient and 
high throughput fashion. It then carries out TFBM enrichment analysis to detect binding sites 
that are enriched within the user’s set of genes. 
 
The subsequent sections of this chapter will focus on the following. Firstly, the concept of 
Position Frequency Matrices and the required terminology is explained. Next in the Methods, 
the implementation of the algorithm and software is described for high throughput TFBM 
detection. The efficiency and biological usefulness of BiSAn is then described by subjecting 
it to microarray data generated from our in-house studies. 
 
3.2 Terminology 
Position frequency matrices (PFMs) represent the most widely employed model for TFBMs 
where each PFM, F = (fσj) consists of a set of TFBMs of length m over an alphabet Σ = 
{A,T,C,G}. A PFM is hence defined as a |Σ| × m matrix, where fσj is the frequency of symbol 
σ at position j 
The information content, Ij (1) and mean information content, I(F) (2) for column j of a 
position frequency matrix, F can be defined as follows: 
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When measuring the quality of a given PFM, the mean information content is used. 
 
3.3 High Throughput scanning of PFMs for promoter analysis 
For a given set of differentially expressed genes, PFMs for x number of TFs can be used to 
scan promoter sequences pertaining to these interesting genes. Because each PFM, F = (fσj), 
the frequency of symbol σ for each nucleotide base A, T, G or C at position j over the length 
of the entire matrix can be used to determine all possible consensus binding sites that have 
the potential to bind to the transcription factors which they belong to. Each consensus can 
then be given a score based on 1) the frequency of each base A, T, G or C at position j of the 
matrix and 2) the total frequency of all bases at position j of the matrix. The subsequent 
scores of each consensus site can then be used to reflect the putative binding affinities of 
these sites to their respective TF, which can facilitate in silico biological predictions. 
The purpose of BiSAn is to provide a simple yet effective medium for biologists to efficiently 
identify putative TFBMs from promoter sites belonging to their genes of interest at the click 
of a button.   
3.4 Methods 
This section describes how the TF data was collected and organized followed by a description 
of the algorithm used to scan promoter sites for the presence of consensus TFBMs. 
[3.1] 
[3.2] 
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3.4.1 Data collection and storage 
The following sets of data were downloaded from the specified sources: 
TF Binding site data: A total of 23 mus musculus PFMs were obtained from the JASPAR 
database (Sandelin et al., 2004). Because each PFM consists of frequencies of each symbol σ 
at position j of the matrix, we derived a consensus TFBM for each matrix as follows. For 
each position j of the matrix, the highest frequency of the symbol σ (A, T, G or C) was taken 
as the first nucleotide base at position j of the consensus. The next most frequent symbol 
from the remaining 3 was then added to the same position of the consensus (separating each 
symbol at that position of the consensus with the / delimiter) until the least frequent symbol 
was added. Symbols with a frequency count of 0 were not added to the consensus. Once 
consensus binding sites were derived from all 23 PFMs, they were stored in an excel file 
together with the PFMs, names, classes, species and accession identifiers of the matrices. 
Promoter data: The complete set of 22,549 mouse promoter sequences were obtained from 
PromoSer (http://biowulf.bu.edu/zlab/PromoSer/), where each promoter sequence consisted 
of a length of 2000 bases upstream and 100 bases downstream of the Transcription Start 
Signal (TSS). MatchMiner (http://discover.nci.nih.gov/matchminer) and the gene Id converter 
(http://idconverter.bioinfo.cnio.es/) tools were used to convert their locus id’s into genbank 
accession Id’s where necessary. The promoter sequences and their corresponding identifiers 
were then stored in an excel file as two separate columns. 
3.4.2 The Scan and Score algorithm 
We have developed an algorithm to scan promoter sequences in search for each consensus 
site representing a PFM of a specific TF. Before the algorithm is executed, the user must 
provide the system with a set of differentially expressed genes as a text file and in the format 
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“Genbank ID”, “Gene name/description” and “Fold Change/Expression value”, each 
separated by a tab delimiter. Following this, BiSAn fetches the promoter sequences using the 
genbank Ids of the input genes at which point the algorithm is executed as shown below. 
 
Calculating similarity scores, S 
Similarity scores are calculated conditional upon a match found between a consensus binding 
site and the region of a given promoter site that contains the consensus. Once a match is 
found, the similarity score S, is calculated by taking the first base of the consensus, retrieving 
it’s score from the matrix and dividing it by the total frequency count of all bases at that 
specific position of the matrix. This calculation is repeated for each and every subsequent 
base of the consensus and once all scores have been calculated, the overall value is derived 
by adding each resulting score followed by dividing the sum by the total length of the matrix 
and then multiplying by 100 to generate a percentage similarity score. 
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3.4.3 Transcription Factor Binding Motif Enrichment Analysis 
Following the identification of specific TFBMs within promoter regions belonging to the 
user’s genes of interest, the next important step is to statistically determine which binding 
motifs are not occurring by chance alone. Therefore, BiSAn was developed to carry out 
Transcription Factor Binding Motif Enrichment Analysis (TFBMEA), which compares the 
number of differentially expressed genes that share a given consensus binding site, with the 
number of genes expected to share that binding site by chance alone. The difference in the 
observed and expected numbers can then be used to generate contingency tables, which can 
in turn be used as a basis to report P values for each binding site by using a hypergeometric 
statistical model. This work is motivated by CORNA, which is a package written in R to 
allow users to test their gene lists for enrichment of microRNA targets in the context of 
KEGG pathways and GO terms (Wu and Watson, 2009). There are also other software tools 
such as FatiGO (Al-Shahrour et al, 2004), GOStats (Falcon and Gentleman, 2007), GSEA 
(Subramanian et al, 2005), and MappFinder (Doniger et al, 2003) that use a hypergeometric 
distribution or a probability distribution to generate P values in the milieu of functional 
annotation.   
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BiSAn firstly generates a 2 x 2 contingency table for each of the 23 consensus binding sites, 
and then it uses the Fisher’s exact test (hypergeometric model) to derive P values from them. 
In order to generate the contingency tables, each consensus binding site is scanned in the 
entire mouse genome (collection of 22,549 promoter sites) and their number of occurrences is 
calculated. Likewise, each consensus binding site is scanned in the promoter regions of the 
user’s set of differentially expressed genes and subsequently counted for their number of 
occurrences. A contingency table for each consensus binding site is then derived as follows: 
 
 
Chosen Not Chosen  Total 
  TFBM  a  b       a + b 
  Absent  c  d       c + d 
  Totals  a + c  b + d        n 
Where: a = No of genes in user’s gene list that contain the binding site 
(chosen from gene list) 
b = No of genes in the genome that contain the binding site minus a (Not 
chosen from gene list) 
c = No of genes in user’s gene list that do not contain the binding site 
(chosen from gene list) 
d = 22,549 (Total no of genes in genome) – (a + b + c) 
n = Sum of each total (Grand total) 
 
 
These contingency tables reflect the degree of enrichment of a given binding site in the user’s 
set of differentially expressed genes (gene list) relative to the entire genome. Once 
contingency tables have been generated for all consensus binding sites, BiSAn then applies 
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the Fisher’s exact test to compute P values for each binding site from their contingency tables 
using the following hypergeometric distribution: 
  
Where  = binomial coefficient and ! = factorial operator 
 
The fundamental motivation behind the development of BiSAn is as follows. Although there 
are software available that specialize in promoter analysis for TFBM detection, complications 
arise for the common biologist who may wish to efficiently analyze their microarray data. 
The most noteworthy problem is related to a lack of consensus for the use of gene identifiers 
when representing genomic data. Because of this, the biologist is faced with the problem of 
ensuring that their microarray data representation complies with the type(s) of identifiers 
required by these software. BiSAn has been specifically designed to accept Genbank 
accession identifiers, which is by far the most commonly used to represent microarray data. 
Furthermore, TFBM detection is usually complicated by a low level of conservation; hence 
matrices are rapidly becoming the chosen methodology for TFBM representation. The goal of 
this work is to take advantage of this methodology for high throughput analysis specific for 
microarray data by providing a simple yet effective pipeline for biologists to detect TFBMs 
that may be implicating the biological phenomenon under investigation. 
 
3.5 Results and Discussion 
BiSAn was written in Perl. Visual Basic.Net was used to construct the Graphical User 
Interface for the output to be displayed to the user. The software and associated data files are 
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freely available and can be downloaded from the project website 
(http://www.1066technologies.co.uk/bisan). BiSAn requires users to provide their data as a 
text file, where the first column contains the genbank accession identifier, the second column 
contains the gene name or description, and the third column contains the expression value or 
fold change (each column separated by a tab delimiter). Once imported, the underlying 
algorithm of BiSAn (section 3.4.2) is executed and the gene identifiers from the input data 
are used to fetch their corresponding promoter sequences. These sequences are then fully  
 
Figure 3.1 The Graphical User Interface (GUI) of BiSAn. The left panel displays the users imported 
gene expression profile and the right panel displays the output from the analysis, including web links, 
which when clicked display the profiles of the relevant Transcription Factor in JASPAR. 
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3.5.1 Application of BiSAn 
To demonstrate the benefits that can be derived from analysing microarray data using BiSAn, 
we utilized data generated from our in-house microarray studies to evaluate how well our 
pipeline could be used to predict new outcomes. The biological question pertinent to this 
study was to unravel the underlying molecular mechanisms dictating immune tolerance by 
analysing the role of Egr-2 in implicating T cell tolerance. Recently characterised as a 
candidate tolerance-inducing transcription factor, the Early Growth Response gene (Egr-2) is 
known to interact with specific genes to implicate the state of tolerance in T cells (Safford et 
al., 2005; Warner et al., 1999). The aim of this microarray experiment was to generate 
differentially expressed genes by comparing tolerant Vs activated CD4+ T cells taken from 
mice, using an oligonucleotide chip consisting of approximately10, 000 known mouse genes 
(the accession number of the array data is e-mexp-283, accessible via the ArrayExpress 
website (http://www.ebi.ac.uk/arrayexpress/)). From this microarray experiment, 70 
differentially expressed genes were identified (fold change >= 1.5) from which 8 genes were 
specifically confirmed to be highly upregulated by Reverse Transcriptase PCR (Table 3.1).  
Table 3.1 8/70 differentially expressed genes confirmed to be highly up-regulated in T cell tolerance 
by Reverse Transcriptase PCR (RT-PCR) 
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We inputted these 70 differentially expressed genes into BiSAn in order to assess its ability to 
carry out TFBM detection under high throughput conditions, whilst determining how well it 
could be used to better understand the molecular mechanisms underlying immune tolerance. 
From the input, 47 genes were found by BiSAn that contained known mouse TFBMs in their 
promoter sequences. A total of 23 TF PFMs were scanned against these promoter sites by the 
algorithm with an overall runtime of less than 7 minutes (Table 3.2). 
 
Table 3.2 Some statistics to show the efficiency of BiSAn when scanning promoter sites for high 
throughput TFBM detection 
 
For each promoter site scanned, BiSAn detected TFBMs pertaining to several different TFs 
(such as GATA1, Klf4, Nobox, Pax4, Pax5, ELF5 and Myb) and where a consensus site was 
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found in the promoter, it efficiently computed the similarity score of the consensus to its 
PFM. Because 8/70 genes from our tolerance dataset were confirmed to be highly regulated, 
we decided to place special emphasis on understanding the results generated for these 
putatively interesting genes. Among several other TFs, BiSAn detected TFBMs for the 
GATA1 Transcription factor in promoter regions of these 8 tolerance-related genes with their 
binding affinities ranging from 47.17% to 32.08% (Table 3.3). Similarly, scores calculated 
for the Klf4 transcription factor ranged from 33.26% to 13.91% (Table 3.3).  
 
 
 
 
 
Gene ID TFBMs Binding 
affinity (%) 
  
68 
 
Table 3.3 Promoter analysis of 8/70 genes tolerance genes (confirmed by RT-PCR) for TFBM 
detection together with scores calculated for each consensus site found in their promoter regions. 
NM_007457 
NM_009168 
NM_009298 
NM_009510 
NM_010548 
NM_013532 
NM_019507 
NM_021396 
 
Transcription Factor = Pax5 
 
 
0 
46.25 
37.50 
33.75 
35.83 
29.58 
31.25 
29.58 
NM_007457 
NM_009168 
NM_009298 
NM_009510 
NM_010548 
NM_013532 
NM_019507 
NM_021396 
 
Transcription Factor = GATA1 
 
 
0 
32.08 
32.70 
42.77 
43.71 
42.77 
0 
47.17 
NM_007457 
NM_009168 
NM_009298 
NM_009510 
NM_010548 
NM_013532 
NM_019507 
NM_021396 
 
Transcription Factor = Klf4 
 
0 
26.09 
33.26 
22.48 
13.91 
N/A 
0 
15.43 
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The GATA binding protein (GATA1) TF is known to differentially suppress the expression 
of CCR5 (a major HIV-1 co-receptor and critical determinant of HIV-1 infection) in stem cell 
derived dendritic cells and primary human T-cell subsets (Sundrud et al., 2005). This is 
indicative that GATA1 plays a role in the induction of immune tolerance. Klf4 has also been 
attributed to suppressing the immune response due to its ability to suppress B cell 
proliferation (Yusuf et al., 2008). Results generated from BiSAn show that these 
aforementioned TFs have the potential to bind to promoter sequences of our 8 genes 
confirmed to be over-expressed in immune tolerance. TFs do not necessarily bind to promoter 
sequences with a 100% binding efficiency in the cell. Hence, scores in the range of 30-50% 
may be significant and may reflect the putative ability of these genes to bind to these 2 TFs.  
 
Once putative binding efficiencies of the motifs have been successfully calculated, the next 
logical step in the analysis is to identify consensus binding motifs that are enriched in the 
user’s gene expression datasets in relation to the entire genome. Hence, BiSAn was 
developed to cater for this function. Solely relying on binding efficiencies of consensus 
sequences can pose a problem at the statistical level because such an approach lacks the 
ability to discern consensus binding sites that are not occurring in the user’s gene list by 
chance alone. In light of this BiSAn implements the TFBM Enrichment Analysis function, 
which generates a 2 x 2 contingency table for each consensus binding site and subsequently 
applies the Fisher’s Exact test to generate a P value for each site (refer to section 3.4.3 for a 
detailed description of the implementation of TFBM Enrichment Analysis). Results generated 
from this enrichment analysis showed that a very few consensus sites were enriched in our 
tolerance dataset since P values generated for most of the sites were quite high (Table 3.4). 
The most noteworthy consensus site belonged to the transcription factor T, with a P value of 
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0.065, which indicates a statistically significant degree of enrichment (Table 3.4). The T 
transcription factor is known to act as an activator of transcription, which binds to its target 
DNA as a homodimer. It is biologically interesting that the consensus binding site for a 
transcriptional regulator was found to be enriched in our immune tolerance dataset because 
there is a possibility that the transcription factor T may be hampered from interacting with 
these genes via the consensus site in order to induce the state of T cell tolerance. However, 
this is something that needs to be confirmed through wet lab experimentations.  
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Table 3.4 Promoter analysis of 8/70 genes tolerance genes (confirmed by RT-PCR) for TFBM 
detection together with scores calculated for each consensus site found in their promoter regions. 
 
JASPAR 
ID 
Transcription 
Factor Name 
Consensus binding site P 
Value 
MA0004 Arnt 
 
0.900 
MA0006 Arnt-Ahr 
 
0.994 
MA0009 T 
 
0.065 
MA0014 Pax5 
 
0.984 
MA0027 En1 
 
0.997 
MA0029 Evi1 
 
0.754 
MA0035 Gata1 
 
1.000 
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MA0039 Klf4 
 
1.000 
 
3.6 Concluding remarks 
In this chapter, we have shown that utilizing PFMs for the purpose of scanning promoter sites 
for high throughput TFBM detection works well for deciphering microarray data. We have 
demonstrated this by developing BiSAn, which is a simple yet effective pipeline for the 
common biologist who may wish to input their gene expression data into a easy-to-use 
software to facilitate efficient TFBM detection. The algorithm underlying BiSAn is 
computationally fast and results generated from it can be used to make valid in silico 
predictions to aid the biologist in answering their research question. 
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Chapter 4 
Genome Interactions Analyzer: a 
systems biology approach for the global 
analysis of transcriptional networks in 
microarray data 
 
4.1 Introduction 
Cis- regulatory sequences are frequently present in the genome, acting as recognition sites for 
the binding between DNA and RNA polymerase. Such regulatory sequences are recognised 
by and subsequently bind to specific transcription factors, which governs the increase or 
decrease of binding between RNA polymerase and genomic DNA. Consequently, the 
strength of the latter binding determines the expression of the specific gene being observed. 
Identifying the potential interactions between transcription factors and genes via these 
regulatory binding sequences is crucial towards enhancing our understanding of molecular 
mechanisms, such as cell differentiation and proliferation because these interactions directly 
implicate gene expression. However, to gain a systems level understanding of cellular 
function, it is equally imperative to identify protein-protein interactions that occur within the 
cell, which may be indirectly affecting transcription (i.e. by a specific protein carrying the 
transcription factor from the cytoplasm to the nucleus). Also, to complete the cellular picture, 
the aforementioned classes of interactions need to be placed in the context of molecular 
pathways to identify the involvement of other biological molecules and signalling cascades 
that may be playing important roles in the molecular mechanism under observation (For a 
review of these classes of interactions, refer to Chapter 2 of this thesis).  
4 
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Although the technological breakthrough of DNA microarrays has revolutionised the field of 
molecular biology by providing a platform for biologists to quantify the mRNA expression 
levels of entire genomes concurrently in a single experiment, such high-throughput 
experiments tend to generate vast amounts of raw data making it problematic for the 
researcher to extract meaningful biological insight. It is at this stage where the use of 
appropriate computational tools becomes necessary for the purpose of mining the raw data to 
yield specific biologically significant data as per the biologist’s needs. The need for data 
mining however, arises not only due to data overload but also more importantly because the 
raw data itself does not provide a complete picture in the context of systems biology due to its 
lack of integration with external sources of knowledge. Hence the use of relevant 
computational tools/software become necessary if the biologist is to gain meaningful 
deductions about their data generated from in-house microarray studies.   
Currently, data pertaining to transcription factor binding sites are stored in database 
applications such as TRANSFAC (Wingender et al., 1996), Jaspar (Sandelin, et al., 2004) 
and the Object-Oriented Transcription Factor Database (TFD) (Ghosh, 1998). In addition, 
there are software available such as Expander (Shamir et al., 2005), INCLUSive (Thijs et al., 
2002), Genesis (Sturn et al., 2002), CONFAC (Karanam et al., 2004) and GEPAS (Herrero et 
al., 2003), that specialise in carrying out promoter analysis of genes from microarray data to 
identify common transcription factor binding sites. Although these applications focus on 
streamlining the analysis flow of microarray data analysis by performing specific functions 
such as k-means clustering, promoter analysis and functional analysis, they do not offer a 
complete systems level approach to analysing gene expression data. This is because they lack 
the faculty to map gene expression data to biological pathways, ultimately providing an 
incomplete biological representation of the user’s data. The lack of such ability impedes the 
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process of obtaining a complete representation because biological pathways can provide vital 
information about how biological systems are organised (Chung et al., 2004). Currently, a 
number of databases exist, which store data related to transcription factor binding sites, 
protein-protein interactions, molecular complexes and pathways. Examples of such databases 
include BIND (Bader et al., 2001), PANTHER (Thomas et al., 2003) and ABS (Blanco et al., 
2006). Whereas the focus of ABS is inclined towards manually curating experimentally 
identified transcription factor binding sites identified in promoters of orthologous vertebrate 
genes and storing this data in the form of a web-based database, its purpose is not to act as an 
interactive software tool that can be used in an automated or semi-automated fashion by its 
users. Hence ABS acts more like a repository of transcription factor binding site information 
rather than a user interactive software. PANTHER (Thomas et al., 2003) and BIND (Bader et 
al., 2001) focus on the storage of high throughput protein sequences, molecular complexes 
and pathways but share the same problem as ABS (Blanco et al., 2006) in terms of acting as 
static databases lacking user-interactive capabilities. Currently, the pathway database of 
KEGG (Kanehisa et al., 2004) forms a central repository of biological pathways. However, 
its pathway diagrams are static in nature and KEGG itself cannot be directly used for the 
purpose of mapping gene expression data to biological pathways. Although users can connect 
to KEGG via a SOAP interface in order to analyse their microarray data, doing so would be 
problematic for biologists who lack the necessary computational skills required to write 
programs. BioCarta (http://www.biocarta.com); another application dedicated to biological 
pathways, allows users to map gene names to biological pathways but on a gene-by-gene 
basis only. 
 The current situation is such that there are no programs available to identify Cis-regulatory 
sequences in genomic promoter sites and protein-protein interactions, from differentially 
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expressed genes coupled with mapping these genes/proteins to an up-to-date repository of 
molecular pathways, all in a single software package. Making such software available is 
essential for biologists, especially for those actively involved in conducting microarray 
experiments to unravel previously unknown molecular mechanisms. This is predominantly 
because gene expression measurements alone are not sufficient to answer complex biological 
questions since they represent the amount of gene expression without explaining the 
molecular causalities that lead to the expression. In light of this, a global approach to 
analysing microarray data is required, where users are able to integrate their gene expression 
data in the context of transcription factor binding sites, protein-protein interactions and 
molecular pathway analysis, all at the same time. Only then will users be able to extract a 
global visualisation of cellular activities, which implicate the molecular mechanism being 
investigated by them.   
In this chapter, a bioinformatics software package called Genome Interactions Analyser 
(GIA) is described, which focuses on the interpretation of data generated from gene 
expression microarray experiments and deciphers it in the context of promoter analysis to 
identify transcription factor binding sites, protein-protein interactions and molecular 
pathways for both mouse and human species all at the same time. GIA specifically aims to 
act as a microarray data analysis system and has been designed to efficiently extract global-
level biological meaning from gene expression data in order to aid in the exploitation of 
molecular mechanisms investigated by biologists. Because GIA is a systems-biology 
software, it forms an attractive medium for biologists to meaningfully analyse their high 
throughput data.    
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4.2 Methodology 
GIA was programmed in Visual Basic.NET and Perl and MySQL was used to construct its 
underlying databases, built for the purpose of generating the hierarchical tree-view structures. 
Before GIA is executed, users are required to provide a tab-delimited text file containing 
gene expression data (in the format: Genbank Accession ID, Fold Change/Expression Value, 
and + or – sign to differentiate up and down regulated genes), which they wish to process. 
Following this the user is required to connect to the MySQL database containing all the 
underlying data used by GIA. Once connected, the user will be able to begin their analysis. 
Refer to Figure 4.1 for a complete illustration of the functions. 
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Figure 4.1 Functional layers of GIA. Once user’s data is queried against GIA’s database, processed 
data is displayed in the relevant panel on the interface, after which the user can obtain a local 
summary of their results (specific to the function of GIA they have executed). Following live 
connection with KEGG, user’s genes are queried against KEGG’s pathway database. Results 
(including the links for each pathway) are then displayed on GIA’s sub-interface. 
 
4.2.1 Gene-Protein Interaction Function 
The first function of the software (called “Gene-Protein Interaction”) is used to generate the 
hierarchical tree-view structure representing the associations of transcription factors, Cis 
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regulatory binding sites and genes containing those binding sites within their promoter 
regions. The associations are organised in the form of grandparent, parent and child nodes 
respectively and each node is built as a result of querying GIA’s database (Figure 4.1 and 
4.2). When this tree-view is queried against the user’s data, genes found within the tree-view 
structure are highlighted in red (for up-regulated genes) and green (for down-regulated 
genes). The colour codes are based on the thresholds that users set for their input data. When 
users import their expression data into GIA, they will be prompted with an option to set their 
thresholds for both up and down-regulated genes. If for example, they choose >+1.5 (for up-
regulated) and <-1.5 (for down-regulated) as their thresholds, genes from their dataset 
(meeting these thresholds) found within the tree-view will be highlighted as red and green 
respectively. Also because the user’s data may also contain transcription factors, these will 
also be highlighted in the tree-view if found. Following this, users can then use this function 
to generate a statistical profile for each cluster of transcription factors, comprising of the 
number of genes, Cis regulatory binding sites and mean fold change expression belonging to 
each cluster. These statistics serve the purpose of identifying clusters of genes from the user’s 
data that are enriched with specific transcription factor binding sites. The purpose of these 
features is for users to identify genes from their gene expression datasets that contain 
regulatory binding motifs for specific transcription factors which can then be correlated to the 
vital information of whether they have been up or down-regulated in their particular 
microarray experiment. Our motivation for designing and implementing this aspect of our 
software revolves around the belief that transcription factor binding sites found within 
promoter sites of genes can play integral roles in governing unknown gene function and 
having additional gene expression information (i.e. Up or down-regulated signals) can aid in 
making predictive inferences about the data at the DNA-Protein interaction level.  
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4.2.2 Protein-protein Interaction Function 
The second panel (called “Protein-protein interactions”) is used to generate a hierarchical 
tree-view structure specific to protein-protein interactions and GIA’s database is queried in 
order to build the tree-view (Figure 4.1 and 4.2). Genbank accession numbers for protein “A” 
are represented as parent nodes while accession numbers for their interacting proteins 
(Protein “B”) are represented as child nodes. Once the protein-protein interaction tree-view is 
queried against the users gene expression data, those genes found within the tree-view are 
highlighted accordingly (Figure 4.2). Because gene expression datasets typically consist of 
accession numbers pertaining to both genes and proteins, having such functionality would 
give biologists the opportunity to identify proteins within their datasets that interact with 
other proteins not necessarily found within their data. At any point in the analysis stage, the 
user can export a local summary of their results, delineating the associations of genes (within 
their dataset) with transcriptions factors to which they have been assigned to (for Gene-
Protein Interaction) or alternatively associations between proteins found within their dataset 
with other interacting proteins (for Protein-Protein interactions). In the case of both types of 
analyses, the exported data also provides names for molecular pathways in which each 
gene/protein is found to play a role in. 
 
4.2.3 Molecular Pathway Analysis 
To gain a systems level understanding of gene expression data, it is essential for the analysis 
to encompass an understanding of what roles user’s genes of interest play in currently known 
molecular pathways. This is important since molecular pathways represent knowledge-base 
and can be used to validate predictive findings. This function of GIA (Pathway Maps 
function) is divided into two specific sub-functions. The first allows users to map their 
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expression data to eight core pathways that are known to be pertinent to a broad range of 
molecular processes (such as immunology and cancer) and the second sub-function allows 
users to map their data to all molecular pathways known to date. The eight core pathways 
were developed specifically for immunologists and cancer researchers interested in efficiently 
analysing their immunology-specific or cancer-specific gene expression data. 
For the first sub-function, the co-ordinates for both the nodes (biological entity) and 
associations (relationships) comprising each pathway are stored in appropriate data 
structures. When the user’s data is queried against the nodes for the biological entities of each 
pathway, a count is provided on GIA’s interface for the number of genes from the user’s data 
that are found in each of the pathways (Figure 4.2). Knowing which pathways are worthy of 
exploration, the user then has the option to select a pathway of their choice. When selected, 
the pathway map is constructed on the sub interface (independent interface) of GIA. 
Concurrently, the fold changes for each gene entry present in the user’s gene expression data 
are searched to establish whether the fold changes are + or – and subsequently, the genes 
from the users data found within the pathway are highlighted accordingly in order to indicate 
to the user the genes that have been up or down-regulated in their particular microarray 
experiment. At this point in the analysis stage, users can export a summary of their pathway 
analysis findings.   
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Figure 4.2 Main Graphical User Interface of GIA. The first panel displays the user’s interesting 
genes, where +/- Signs are used to indicate up or down-regulated genes. The second panel called 
“TFA” is used to display the hierarchical structure representing the associations between transcription 
factors, binding sites and genes. Those genes found within the user’s data are highlighted accordingly. 
The third panel called “protein-protein interaction tree-view” is used to generate the hierarchical 
structure representing the protein-protein interactions. Finally, for each local pathway, a count is 
provided which reflects the number of genes from the user’s data found within the pathways. Clicking 
on either organism type (mus musculus or homo sapiens) generates the pathway maps. Also, clicking 
on the “connect to KEGG live” button takes the users to the sub-interface, where they can map their 
expression data to live KEGG pathways at the click of a button. 
 
For the second sub-function, GIA has been designed to automatically connect to KEGG 
(Kanehisa et al., 2004) in a live fashion in order to map user’s gene expression data to all 
molecular pathways known to date. Once GIA has searched for the user’s genes in all KEGG 
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pathways, the pathway links are displayed on the second sub-interface of GIA (Figure 4.3). 
Clicking on each of these links will generate the specific KEGG pathway in html and the 
user’s genes will be highlighted in red or green depending on whether the genes are up or 
down regulated (Figure 4.4). In order for GIA to establish a live connection with KEGG’s 
pathway database, the KEGG API is accessed in Perl. Also, Perl script was written for GIA to 
specifically 1) search for user’s genes in all of KEGG pathways, 2) return the results of the 
search (including pathway links) to GIA’s sub-interface for users to scrutinise and 3) 
highlight user’s genes as red or green on KEGG pathways once each pathway link is clicked. 
GIA has been designed to connect to the KEGG API via Soap-Lite, after which the algorithm 
is executed (Figure 4.5). 
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Figure 4.3 Sub-Interface of GIA. User’s genes are searched in KEGG’s pathway database and results 
are sent back to GIA’s sub-interface for scrutiny. Clicking on each url generates the pathway image 
with user’s genes highlighted in them. Users’ can select from a number of gene identifiers, such as 
Genbank, Entrez, Unigene and NCBI id’s to perform the search. 
 
4.2.4 Constructing the databases for GIA 
 
4.2.4.1 Gene-Protein Interaction Database 
The Gene-Protein Interaction database was constructed in three steps. At first, data from the 
Object-Oriented Transcription Factor Database (oo-TFD) (Ghosh, 1998) was manipulated, 
which contains a list of 1617 unique eukaryotic transcription factors associated with their 
respective binding sites, all verified according to relevant wet-lab experiments. Then, we 
obtained the complete set of human and mouse promoters, using EXPANDER (Shamir et al, 
2005) and Promoser’s (Halees et al., 2003) underlying databases respectively. The set of 
collected human promoter data comprised of 12,981 putative promoter regions for known 
genes, each with a length of 1200 bp (1200 bp upstream of the TSS). For the mouse data, 
each promoter sequence contains 2000 bases upstream and 100 bases downstream of the TSS. 
Having obtained all the necessary data, we then created a parallel pattern finding algorithm to 
search for the transcription factor binding sites within the entire human and mouse promoter 
sites. Since there are vast numbers of promoters within the human and mouse genomes, the 
algorithm needed to be of a distributed type in order to improve processing efficiency. Once 
binding sites of the 1617 transcription factors were found within the complete sets of human 
and mouse promoter sites, the genes to which the promoter sites belonged to were assigned to 
the transcription factors. A total of 320,000 genes for human (including multiple occurances) 
and 300,000 for mouse (including multiple occurances) were assigned to 1617 transcription 
factors by the pattern-matching algorithm. Where necessary, Matchminer (Bussey et al., 
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2003) was used to convert gene identifiers from one type to another. For example, when the 
human promoter data was collected, each gene identifier was originally presented as “locus 
id”. In this case, Matchminer was used to convert these identifiers to Genbank accession ID. 
 
4.2.4.2 Protein-Protein Interaction Database  
The Protein-Protein Interaction database was constructed using human interaction data from 
the Human Protein Reference Database (Peri et al., 2003) and mouse interaction data from 
the Riken Database for mouse (Suzuki et al., 2001). A total of 8000 known human protein-
protein interactions were stored together with approximately 145 mouse protein-protein 
interactions where proteins within both sets of interaction data were represented as Genbank 
accession ID’s.  
 
4.2.4.3 Pathway maps Data   
 The pathway data for the eight core pathways comprises of co-ordinates belonging to the 
nodes (biological entities) and associations (arrows and lines). These co-ordinates were 
obtained from KEGG (Kanehisa et al, 2004) and subsequently stored in data structures. By 
having co-ordinates for all biological entities and associations, each pathway map was then, 
designed to be generated automatically. For the live KEGG function of GIA, constructing a 
database was not required since this function was programmed to be executed via the KEGG 
API using Soap-Lite. 
The underlying driving force behind the development of GIA is straightforward. Regardless 
of the nature of the biological question, every microarray experiment will lead to the 
generation of a set of differentially expressed genes. Such set of genes then need to be mined 
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in the appropriate biological context in order to better understand the molecular mechanism 
under investigation. The challenge however, is to carry this out in the perspective of systems 
biology, by not losing the bigger picture of the organism as a whole. GIA was developed  
 
 
Figure 4.4 KEGG pathway, displaying the T-Cell receptor signalling pathway. User’s gene 
expression dataset is searched through all of KEGG’s pathway maps and genes that are found on the 
pathways are highlighted. CD4/8 was upregulated in our tolerance dataset and was found in the T cell 
receptor signalling pathway (highlighted in red).  
whilst considering this in mind, and as a result, the implemented functions were designed to 
streamline high throughput analysis in the context of three principal layers; A) The promoter 
level – Identifying Cis regulatory binding sites in promoter sites of genes that have the 
potential to bind to specific transcription factors, B) The cytoplasmic level – Identifying 
proteins that can interact with other proteins in the cellular cytoplasm, and C) The pathway 
level – Mapping molecular interactions and signalling cascades that occur in molecular 
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pathways within the cell. The potential benefits that could be derived from analysing high 
throughput data within this framework motivated us to develop GIA. The Graphical User 
Interface of GIA coherently reflects the faculty to analyse expression data at these functional 
layers and it has been ensured that the software is easy to use, and that results are processed 
intuitively. 
 
Figure 4.5 Algorithm for GIA’s Live KEGG function. GIA is firstly required to establish a 
connection to KEGG’s API via Soap-Lite. Once connected, the gene ids within the user’s expression 
data are converted into KEGG ids. Following this, the KEGG ids are used to fetch all pathway ids 
(which contain each specific KEGG id within the pathway maps) from the KEGG pathway database. 
The KEGG ids are then mapped to their respective pathway maps and colour coded appropriately and 
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finally, the urls for all of the mapped pathways are sent back to GIA’s sub-interface. Clicking on each 
url generates the pathway map in html with the highlighted genes.  
 
4.3 Results 
For the purpose of demonstrating our software’s functionalities, we used data generated from 
our in-house microarray experiment. The biological purpose of this in-house study centred on 
the exploitation of the underlying molecular mechanisms concerning immune tolerance and 
hence, this forms our basis for further investigation. Microarray datasets were utilised to 
extract interesting biological knowledge from our software via three approaches.  The first 
through the simultaneous identification of DNA-binding transcription factors that have the 
potential to bind to genes within a given microarray dataset, the second via protein-protein 
interactions and the third through a dynamic graphical approach allowing the visualisation of 
genes and proteins within the context of biological pathways (Figure 4.2). 
4.3.1 Analysing the molecular mechanism underlying immune tolerance using GIA’s 
Gene-Protein Interaction function 
Gene-Protein Interaction allows valid inferences to be made about microarray data because it 
combines knowledge of transcription factors, Cis regulatory binding sites and genomic 
promoter sites with the crucial information of whether the genes being analysed have been up 
or down-regulated in the user’s microarray experiment. We chose to use ~ 7000 regulatory 
binding sites from TFD to construct the Gene-Protein Interaction database because these 
binding sites are evolutionarily conserved in eukaryotic genomes and have been verified by 
wet lab experimentations. As part of the Gene-Protein Interaction function, genes found to 
contain evolutionarily conserved binding sites for their respective transcription factors are 
also searched in the pathway database of KEGG in order to integrate the user’s regulatory 
binding site data with molecular pathway information.  
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Because we are interested in the molecular mechanisms underlying T-cell anergy and 
tolerance, we exploited this particular function of our software by utilising differentially 
expressed genes associated with T-cell tolerance. Querying Gene-Protein Interaction against 
our immune tolerance dataset revealed several transcription factors that could potentially bind 
to the genes involved in immune tolerance (Table 4.1). Amongst the differentially expressed 
genes within our tolerance dataset, AXIN1 was found to contain Cis regulatory binding sites 
within its promoter region for the EGR-2 transcription factor. Furthermore IL-10 was found 
to contain Cis binding sites for AP1 and STAT factors, while Ifnar contained binding sites for 
AP1 and STAT 3. When integrated with molecular pathway data, these genes were identified 
to be involved in the Jak-Stat, Cytokine-cytokine and T-cell receptor signalling pathways 
(Table 4.1).   
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Table 4.1 Some differentially expressed genes from the tolerance dataset assigned to their respective 
Transcription factors by GIA 
Transcription 
Factor (TF)  
Accession 
ID of 
gene(s) (*) 
HUGO ID of 
gene (s) 
(**) 
Differential 
Expression 
(***) 
Pathway 
Involved 
(****) 
 
 
Citation 
(*****) 
STAT 3 NM_010508 Ifnar1 +3.521 JAK-STAT Pfeffer et 
al., 1997 
STAT 3 NM_018731 Atp4a +4.058 JAK-STAT ~ 
STAT Factors NM_010548 Il10 +1.796 JAK-STAT Benkhart et 
al., 2000, 
2003 
EGR-2 NM_013866 Zfp385 +1.664 Unknown ~ 
EGR-2 AF009011 Axin1 +2.571 Cell cycle ~ 
EGR-2 NM_007669 P21cip1 +4.512 Cell cycle ~ 
EGR-2 NM_009875 p27kip1 +4.254 Cell cycle ~ 
E-BOX Factors NM_013488 Cd4 +4.905 T-Cell 
receptor 
signalling 
~ 
 
E-BOX Factors 
 
NM_013652 
 
Ccl4 
 
+3.51 
Cytokine-
cytokine 
Interaction 
~ 
E-BOX Factors NM_008420 Kcnb1 +4.825 Unknown ~ 
 
AP-1 
 
NM_013652 
 
Ccl4 
 
+3.51 
Cytokine-
cytokine 
Interaction 
~ 
 
AP-1 
 
NM_019568 
 
Cxcl14 
 
+4.334 
Cytokine-
cytokine 
Interaction 
[20] 
AP-1 NM_010508 Ifnar1 +4.058 JAK-STAT ~ 
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AP-1 NM_010548 Il   10 +3.521 JAK-STAT [21] 
 
(*) Accession Id’s of some of the genes from the tolerance dataset that contain binding sites in their 
promoters for the transcription factors shown in the first column. (**) Corresponding Hugo Id’s of 
each gene. (***) Differential expression of genes (+ indicates genes that are up-regulated). (****) 
Pathways in which the corresponding genes are found in. (*****) Citations for interactions between 
TF and gene (Interactions found by GIA that are not confirmed by published works are denoted by 
“~”). The complete table of differentially expressed genes can be found in the supplementary 
information. 
 
The significance of integrating interaction data between transcription factors and genes with 
molecular pathways is to allow users of our software to 1) identify key transcription factors 
that may be playing important roles in the underlying molecular mechanisms being 
investigated in the microarray experiment and 2) identify other potentially important 
molecules within known biological pathways that may be directly or indirectly implicating 
the molecular mechanism under observation. The gene expression/fold change measurements 
can then be used to assess the likelihood of binding between the gene and transcription factor. 
 
4.3.2 Mining gene expression data specific to Immune tolerance using Protein-Protein 
Interaction function 
Besides  carrying  out  promoter  analysis  to  identify  transcription  factors  that  can 
potentially bind to genes within gene expression datasets, the focus of GIA is also to identify 
gene-encoding proteins within expression data, which participate  in Protein-protein  
interactions  (PPI).  Having  a  functionality  to  analyse  such  interactions  is important in a 
software package that specialises in microarray data analysis since the regulation  of  
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molecular  mechanisms  tend  to  be  dependent  on  gene-specific transcription  factor  
binding  as well  as  interactions  at  the  protein-protein  level. The PPI  function  of  GIA  
has  been  developed  to  naturally  ensure  the  identification  of protein-encoding  genes  
from  user’s  gene  expression  data, which  interact with  other genes within the same dataset. 
However, certain proteins not present within the gene expression dataset may also participate 
in interactions with genes within the user’s data. GIA  is  also  able  to  identify  these  
interactions  that  are  external  to  the  user’s dataset,  leading  to  the  generation  of  
meaningful  information  for  the  users.  Each identified  protein  is  highlighted  either  red  
or  green  within  the  Protein-protein hierarchical structure  (Figure 4.2). Following this, 
proteins are then mapped to known biological pathways to identify their interactions with 
other genes/proteins (Table 4.2).   
 
Table 4.2 Protein-Protein Interactions found for some of the genes within the tolerance dataset, by 
GIA’s Protein-Protein interaction function 
Protein A 
(*) 
Differential 
Expression 
(**) 
 
HUGO 
ID’s for 
Protein A 
(***) 
Protein B 
(****) 
HUGO 
ID’s for 
Protein B 
(*****) 
Pathways 
Involved 
(******) 
Citation 
(*******) 
NM_013787 +2.067 Skp2 NM_007633  Ccne1 Cell Cycle [22] 
NM_013787 +2.067 Skp2 NM_009875  Cdkn1b Cell Cycle [23] 
NM_009987 +1.625 Cx3cr1 NM_009142  Cx3cl1 
Cytokine-
Cytokine 
Interaction 
[24] 
NM_013822 +1.696 Jag1 NM_010928  Notch2  [25] 
NM_008783 +1.829 Pbx1 NM_008714  Notch1  [26] 
NM_009875 +2.227 Cdkn1b NM_009870  Cdk4 Cell cycle, 
T-Cell 
[27] 
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receptor 
signalling 
NM_009875 +2.227 Cdkn1b NM_009873  Cdk6 Cell Cycle [27] 
NM_009875 +2.227 Cdkn1b NM_016714  Nup50 Cell Cycle [28] 
NM_007560 +1.566 Bmpr1b NM_007553  Bmp2 
Cytokine-
Cytokine 
Interaction 
[29] 
NM_007560 +1.566 Bmpr1b NM_007554  Bmp4 
Cytokine-
Cytokine 
Interaction 
[30] 
NM_011529 +2.228 Tank NM_019777  Ikbke  [31] 
NM_011850 +1.587 Nr0b2 NM_030676  Nr5a2  [32] 
 
(*) Accession id’s of some of the protein-encoding genes (Protein A) from the tolerance dataset that 
were found to participate in PPI’s by GIA. (**) Fold Change value of Protein A. (***) HUGO id’s of 
Protein A. (****) Accession id’s of interacting proteins (Protein B). (*****) HUGO id’s of Protein B. 
(******) Pathways in which the interactions are found in. (*******) Citation(s) for each PPI between 
Protein A and B. The proteins highlighted in bold belong to the tolerance dataset, whereas the un-bold 
ones are external proteins not found within the user data.  
 
Querying the Protein-Protein interaction function of GIA against our tolerance-related dataset 
revealed 10 specific protein-encoding genes within the dataset (comprising of ~2000 genes  
in  total), which  collectively  participate  in  a  total  of  15 Protein-protein interactions  with  
proteins  external  to  the  tolerance  dataset  and  2  interactions  with proteins within the 
same tolerance dataset (Table 4.2). Amongst the 15 interactions, the Cdkn1b protein-
encoding gene from  the  tolerance dataset was found  to interact with Cdk4, Cdk6  and 
Nup50  and  from  the  2  internal  interactions, Cdkn1b was  found  to interact with Skp2. 
Also Jag1 and Pbx1 were found to interact with the Notch2 and Notch1 proteins respectively.  
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Pathway analysis  revealed  the  involvement  of  these proteins  in  processes  such  as  cell  
cycle,  T-cell  receptor  signalling  and  Cytokine-cytokine interaction (Table 4.2).  
 
4.3.3 Biological  Pathway  analysis  of  genes  involved  in  T-cell  tolerance  using  GIA’s 
Pathway maps function   
GIA’s pathway maps function is based on 1) the construction of 8 core widely used 
biological  pathways  for  known  cellular  and  molecular  mechanisms  and  2) the 
software’s  ability  to  connect  to  KEGG  in  a  live  fashion  in  order  to  map  users 
expression data to all biological pathways known to date (Figure 4.3 and 4.4). Executing both 
of  these  functions against our  tolerance dataset, we  identified  specific  genes mainly 
involved  in  the  cell  adhesion,  T-cell  receptor  signalling,  Cytokine-Cytokine interaction,  
Jak-Stat,  and  MAP  Kinase  pathways  (Refer  to  Table  4.3  for  complete results). Our 
tolerance gene expression dataset comprised of 70 upregulated genes, 27 of which were 
mapped on to a total of 63 KEGG biological pathways at the click of a button (Table 4.3).   
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Table 4.3 Number and identities of each KEGG pathways mapped for 27/70 genes from our tolerance 
dataset. 
Gene ID (*) KEGG Pathway 
Ids (**) 
Total number of 
pathways (***) 
Gene ID 
(*) 
KEGG 
Pathway 
Ids (**) 
Total number of 
pathways (***) 
 
 
NM_007381 
mmu00071, mmu00280, 
mmu00410, mmu00640, 
mmu03320 
 
 
5 
NM_013542 mmu04650 
mmu04940 
2 
NM_007581 mmu04010 1 NM_010548 mmu04060 
mmu04630 
mmu04660 
3 
NM_007664 mmu04514 1 NM_013652 mmu04060 
mmu04620 
2 
 
NM_008008 
mmu04010, mmu04810, 
mmu05218 
 
3 
NM_009510 mmu04670 
mmu04810 
2 
NM_013488 mmu04514 
mmu04612 
mmu04640 
mmu04660 
4 NM_008205 mmu04514 
mmu04612 
mmu04940 
3 
NM_008420 mmu04742 1 NM_013814 mmu00512 
mmu01030 
2 
NM_011696 mmu04020 1 NM_013521 mmu04080 1 
NM_011125 mmu03320 1 NM_008601 mmu05218 1 
NM_019568 mmu04060 
mmu04670 
2 NM_019777 mmu04010 
mmu04620  
2 
NM_016772 mmu00350 
mmu00362  
mmu00628 
3 NM_010102 mmu04080 1 
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NM_010508 mmu04060 
mmu04620 
mmu04630 
mmu04650 
4 AF303831 mmu00051 
mmu00052 
mmu00120 
mmu00260 
mmu00310 
mmu00363 
mmu00591 
mmu00625 
mmu00650 
9 
NM_021396 mmu04514 1 AF009011 mmu04310 
mmu05210 
mmu05213 
mmu05217 
4 
NM_013490 mmu00260 
mmu00564 
2 AF288381 mmu04650 1 
 
(*) Genebank accession Ids for genes from our tolerance dataset, (**) Ids for KEGG pathways in 
which tolerance-related genes were found in, (***) total number of pathways found for each gene. 
These molecular interactions are all based on known literature and details of these interactions can be 
seen in the specified KEGG pathways 
 
4.4 Discussion 
The motivation behind  the  development  of Genome  Interaction Analyser  (GIA) is  to  
focus  on  streamlining  the  process  of  gene  expression  data  analysis with a special 
emphasis towards systems biology. Since the completion of the human genome project in the 
year 2000, vast amounts of data ranging from promoter sites of various  organisms  to  
identification  of  transcription  factor  binding  sites,  protein-protein interactions  and  
pathway  data  have  been  generated.  However, there is currently a lack of integration of 
these data in the form of user-interactive software. 
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The  focus  of  our  software was  to  give  priority  to motif  prediction  for transcription 
factor binding followed by exploring biological pathways to validate predictions made by 
GIA. The same holds true for our software’s Protein-protein interaction capability in which 
the protein interactions found are mapped to biological pathways to verify the interactions.  
Making  such  software  available  is a  necessity  especially  for biologists  conducting  
microarray  experiments  because  whilst  gene  expression measurements represent the 
quantity of mRNA expression, they cannot solely be used to determine  the molecular 
causality of gene expression. Consequently, GIA aims to extract biological meaning from 
gene expression data by exploiting it in the context of gene-transcription factor binding, 
Protein-protein interactions and molecular pathways. 
By putting our software to use, we were able to explore mechanisms underlying T-cell 
specific tolerance. The process of immune tolerance is highly complex and may involve the 
concerted action of several key  transcription factors, which interact with specific  genes  at  
the  protein-DNA  level  as  well  as  at  the  protein-protein  level  to induce  the  state  of 
tolerance  in  B  and  T  cells.  The Early Growth Response gene (EGR-2) is one of such 
transcription factors that has recently been characterised and although it has been extensively 
studied in the context of the nervous system, its exact role in the immune system has not been 
clearly described. However, recent studies have shown that EGR-2 is a likely candidate to 
play a role in the induction of T-cell anergy/immune tolerance (Safford et al., 2005; Warner 
et al., 1999) and has been found to be up-regulated in tolerised T-cells.  Further  studies  have  
shown  the  over-expression  of  EGR-2  in  microarray experiments  investigating 
mechanisms  underlying T-cell  anergy,  hence  indicating  a negative  regulatory  effect  of  
EGR-2  towards  T-cell  activation  (Anderson et al., 2006).  Interestingly following  
promoter  analysis,  our  software  identified  the  p21cip1  and  p27kip1  gene promoters to 
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contain conserved binding site regions for Egr-2. More specifically, the promoter regions of 
both of these genes were found to contain the GAGGGGGCG and GGGGAGGCG binding 
sites respectively.  Both p21cip1 and p27kip1 were highly up regulated in our microarray 
tolerance dataset (Table 4.1). Furthermore, results from gene  shift analysis have  specifically 
confirmed  these  interactions,  suggesting a possible  mechanism  via  which  Egr-2  
regulates  immune  tolerance  (manuscript  in preparation).   
Zfp385 (a zinc finger protein) and AXIN1 (also highly upregulated  in our  tolerance data  
(Table  4.1))  were  both  found  to  contain  the CCGCCCCCGC  binding  site  for EGR-2 
within their promoter regions. The role of AXIN1 is known to be involved in the negative 
regulation of the Wnt signalling pathway, and has also been attributed to the induction of 
apoptosis (Satoh et al., 2000). Pathway analysis from GIA revealed the identification of 
AXIN1 in the cell cycle. This leads to the inference that EGR-2 may interact with AXIN1’s 
promoter region to induce tolerance since both molecules are known to act as negative 
regulators of T-cell proliferation. However, studies are yet to confirm this interaction.   
STAT3,  another  transcription  factor,  plays  a  critical  role  in  the  induction  of T-cell 
tolerance  in  CD4+  T-cells  and  antigen  presenting  cells  (APC’s)  devoid  of  this 
transcription factor have known to effectively break antigen specific T-cell anergy in vivo, 
implicating its role as a negative regulator of T-cell activation (Cheng et al., 2003). Studies 
have closely  analysed  the  promoter  site  for  interleukin-10,  a  cytokine  known  to  
downregulate the  immune  response,  and  identified  a  module  consisting  of  an  IFN 
regulatory  factor 1  (Irf-1)  binding  site and a Stat3  binding  site  (Ziegler-Heitbrock et al., 
2003). Based on these studies,  it  has  been  identified  that  the  interleukin-10  gene  binds  
to  the  Stat3 transcription  factor  and  is  consequently  up-regulated  by  Stat3,  ultimately  
playing  a role in tolerance (Cheng et al., 2003; Ziegler-Heitbrock et al., 2003). From the 
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imported tolerance data, GIA identified the Ifnar1 interferon  (alpha  and  beta)  receptor  1  
gene,  which  was  highly  expressed  in  our tolerance data and  showed  that  it contains  the 
TTCCGGAA  binding  site  for  the Stat3 transcription  factor,  which  has  been  confirmed  
by  Pfeffer’s  research  group (Pfeffer et al., 1997), reporting  that  Stat3  is  able  to  bind  to  
this  receptor. Pathway analysis from GIA revealed the identification of Ifnar1 in the Jak-Stat 
pathway. This suggests a potential target  for  further  investigation  since  Stat3  signalling  
has  been  reported  to  play  a critical role in immune tolerance (Benkhart et al., 2000).   
There  are  several  bioinformatics  software  packages  that  specialise  in  the  high 
throughput  analysis  of  gene  expression  data,  such  as Expander  (Shamir et al., 2005), 
INCLUSive (Thijs et al., 2002), Genesis (Sturn et al., 2002), CONFAC (Karanam et al., 
2004), GeneACT (Cheung et al., 2006) and GEPAS (Herrero et al, 2003), which we tested 
with our in-house  immune  tolerance  gene  expression  data.  However, GIA has some 
advantages over such tools. Conceptually, there is presently no software available that 
integrates 1) the discovery of transcription factor specific Cis regulatory binding sites within 
promoter regions of genes, 2) the identification of protein-protein interactions and 3) 
mapping/overlaying of genes/protein to an up-to-date repository of molecular pathways  all  
at  once  for  high  throughput  data  analysis  (Table  4.4).  In  addition, the binding  sites  
underlying  the  Gene-Protein  interaction  function  of  GIA  represent evolutionarily  
conserved  genomic  regions,  which  are  used  by  our  software  to highlight  potential  
interactions  between  transcription  factors  and  genes  from  the user’s expression data 
without the use of clustering algorithms, which tend to generate arbitrary  clusters  of  genes  
prior  to  carrying  out  functional/promoter  analysis. Furthermore, GIA’s pathway maps 
function is based on an efficient algorithm, which was  programmed  to  connect  to  the API  
interface  of KEGG  in  a  live  fashion. This algorithm  has  been  designed  to  map  several  
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different  gene  identifiers  to  KEGG pathways  (GenBank, Entrez, UniGene and NCBI), 
hence maximising the  output  for pathway analysis.   
 
Table 4.4 A comparison of GIA with other software tools 
Function 
 
 
GIA 
 
 
EXPANDER 
 
INCLUSIVE 
 
Pathway 
Studio 
 
MAPPFinder 
 
BIND 
 
MicroCore 
 
KEGG 
 
BioCarta 
 
 
 
GeneACT 
 
Suitable for 
high 
throughput 
data analysis 
 
YES 
 
YES 
 
YES 
 
YES 
 
YES 
 
NO 
 
YES 
 
NO 
 
NO 
 
YES 
Carries out 
Promoter 
Analysis/TF 
Assignment 
 
YES 
 
YES 
 
YES 
 
NO 
 
NO 
 
NO 
 
NO 
 
NO 
 
NO 
 
YES 
Searches for 
transcription 
factors in 
users data 
 
 
YES 
 
 
NO 
 
 
NO 
 
 
NO 
 
 
NO 
 
 
NO 
 
 
NO 
 
 
NO 
 
 
NO 
 
NO 
Protein-
Protein 
Interaction 
analysis 
 
YES 
 
NO 
 
NO 
 
YES 
 
YES 
 
YES 
 
YES 
 
NO 
 
NO 
 
NO 
Construction 
of pathway 
maps 
 
YES 
 
NO 
 
NO 
 
YES 
 
YES 
 
NO 
 
YES 
 
YES 
 
YES 
 
NO 
Reveals 
transcription 
factor 
binding sites  
 
YES 
 
NO 
 
NO 
 
NO 
 
 
NO 
 
NO 
 
NO 
 
NO 
 
NO 
 
YES 
Mapping 
gene 
expression 
data to 
pathway 
maps 
 
YES 
 
NO 
 
NO 
 
YES 
 
 
YES 
 
NO 
 
NO 
 
 
NO 
 
NO 
 
 
NO 
Basis for Motif Gene Gene  Functional     Motif 
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(*) This criterion is used to identify software tools that have the capability to integrate transcription 
factor, protein-protein and pathway analysis all in a single package. 
 
4.5 Conclusion 
GIA  is  a  powerful  systems  biology  software  package  for microarray  data analysis, 
which offers specific functions to its users such as simultaneous promoter analysis of genes 
within expression data in order to assign genes to specific transcription factors, identification 
of protein-protein interactions and finally, mapping of several hundreds or  thousands  of 
genes  to all KEGG  biological pathways known  to date. We believe that  such  an overall  
package  is  extremely  useful  for  biologists  in  general,  but more specifically  for  
microarray  data  analysts  who  are  in  need  of  quick  computational solutions to complex 
biological problems.  
4.6 Future Work 
Chapter 3 addressed the importance of using a hypergeometric model such as the Fisher’s 
exact test to generate P values in order to discern transcription factor binding sites that do not 
occur in the user’s gene list by chance alone. Through the implementation of this 
transcription factor binding motif enrichment analysis method in BiSAn, we were able to 
demonstrate the importance of computing a P value for each binding motif. The very same 
Prediction Discovery Expression 
Clustering 
Expression 
Clustering 
N/A Enrichment 
using GO 
N/A N/A N/A N/A Discovery 
User 
interactive 
software (S) 
or Database 
(D) 
 
S 
 
S 
 
 
S 
 
S 
 
S 
 
D 
 
S 
 
S 
 
S 
 
S 
Integrative 
capability (*) 
YES NO NO NO NO NO NO NO NO NO 
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approach can be implemented in GIA, and this is something that will be addressed as a future 
work. The methodology will entail generating a 2 x 2 contingency table for each of the 7000 
unique transcription factor binding sites that belong to 1617 unique transcription factors, 
followed by implementing the Fishers exact test to generate a P value for each binding site. 
This will provide a medium for biologists to carry out binding site enrichment analysis for 
their gene expression datasets, which will narrow down their focus to include those binding 
sites that generate statistically significant P values.  
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Chapter 5 
MicroPath: A software pipeline for the 
comparison of multiple gene expression 
studies to identify cellular transcriptional 
states 
 
5.1 Introduction 
The fundamental virtue of microarray technology lies in its ability to provide a global 
snapshot of the cellular state in the context of any given biological condition. This has 
spawned opportunities for biologists to simultaneously quantify mRNA transcript levels of 
entire genomes concurrently in order to observe specific transcriptome states. Although each 
cell of an organism contains an exact copy of its genome, the expression patterns of genes 
can vary due to different biological conditions, giving rise to different transcriptome states. 
However, the immensity of raw biological data generated from microarray experiments in the 
form of thousands of gene expression data points poses a challenge for biologists to extract 
such biological meaning from these overwhelming volumes of data. Furthermore, even if 
such data is statistically analysed to yield a set of differentially expressed genes, there will 
still be a need to integrate these sets of genes with external knowledge banks in order to make 
valid biological inferences. These challenges become increasingly difficult when considering 
the cross comparisons of multiple biologically related gene expression datasets.  
Because high throughput technologies such as microarrays have rapidly gained popularity at 
a global scale due to the prospect of quantifying gene expression in a high throughput fashion 
and subsequently identifying previously unknown transcriptome states, gene expression data 
5 
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pertaining to various different biological questions are being rapidly generated by scientists 
worldwide. Such data sets are now readily accessible through public repositories such as 
ArrayExpress (Sarkans et al., 2005) and the Gene Expression Omnibus (GEO) (Barrett et al., 
2006). This has motivated biologists to utilise these sets of data in an attempt to investigate 
common regulatory signatures that can be potentially found across multiple experiments 
sharing a similar biological theme. One of the most common methods of comparison is based 
on the assumption that genes across different biological conditions having similar expression 
patterns are likely to be involved in the same biological process (Rhodes et al., 2004) and 
hence, may share the same regulatory signatures. Using this method of comparison, which is 
one of the most successful methods to date, coupled with the availability of publicly 
accessible gene expression data repositories, biologists now have the opportunity to answer 
complex biological questions pertaining to biological phenomena underlying various 
different disease states. However, there is currently a lack of software tools that have the 
potential to maximise the benefits that can be derived from the cross comparison of multiple 
gene expression datasets. 
 Because signals pertinent to transcriptome states tend to be diluted over entire datasets, it is 
imperative that specialised software tools are developed that cater for the need of extracting 
such information buried within masses of gene expression data points. There are currently 
few applications such as MiCoViTo (Lelandais et al., 2004) that specialise in the analysis of 
transcriptome states from expression datasets by using a gene-centric approach. However, 
this is only relevant to the yeast genome and hence, cannot be applied to data generated from 
the use of other organisms. Furthermore, there are several interfaces and applications such as 
KEGG (Kanehisa et al., 2004), GenMapp (Salomonis et al., 2007), Reactome (Vastrik et al., 
2007) and Ingenuity Pathway Analysis (www.ingenuity.com), which allow biologists to 
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analyse their expression data at the cellular level. In addition, data relevant to transcription 
factor binding sites are stored in database applications such as TRANSFAC (Wingender et 
al., 1996), Jaspar (Sandelin, et al., 2004) and the Object-Oriented Transcription Factor 
Database (TFD) (Ghosh, 1998). With so much wealth of data available, it would be highly 
fruitful to integrate these external sources of knowledge in the milieu of multiple gene 
expression data analysis. 
In this chapter we introduce a novel bioinformatics software pipeline called MicroPath, 
which specializes in the cross comparison of multiple gene expression datasets and attempts 
to identify common regulatory signatures from the standpoint of molecular pathway analysis. 
When one scrutinizes current literature relevant to automated solutions of gene expression 
analysis, it becomes apparent that there is an increasing demand for software applications that 
offer an efficient pipeline to the analysis of multiple gene expression profiles. Although 
current meta-analyses studies have been conducted with the purpose of employing statistical 
techniques to compare cDNA and affymetrix gene expression profiles (Ghosh et al., 2003; 
Rhodes et al., 2002, 2004; Wang et al., 2004), it cannot be denied that there is a mounting 
need for this process to be automated. Nevertheless, various approaches/algorithms of 
statistical nature have already been implemented with the purpose of identifying the most 
relevant pathways in a given experiment (Draghici et al., 2007; Stelling et al., 2004; Joshi-
Tope et al., 2005) together with methods such as Gene Set Enrichment Analysis (GSEA), 
which ranks genes based on the correlations between their expressions and observed 
phenotypes in the context of biological pathway discoveries (Subramanian et al., 2005). 
There are also tools available that functionally annotate gene expression data (Khalid et al., 
2006a, 2006b). Albeit, it remains infeasible for biologists to cross compare several expression 
profiles without an automated solution, and hence they are faced with the labour-intensive 
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task of employing manual methods to carry out their comparisons. MicroPath uses the meta-
analytic standard and has been specifically developed to: compare several significantly 
expressed sets of genes in order to find the intersection of common genes using both number 
crunching methods as well as the classical permutation and combination principle, extract 
putative regulatory signatures using statistical and graph-based approaches and finally, 
mapping these sub-sets of co-expressed genes to molecular pathways all in the form of a high 
throughput pipeline. 
 
5.2 Implementation 
The front-end of MicroPath was developed in Visual Basic.Net and Perl, and the database 
back-end was developed in MySQL. Upon analysing the users input files (gene expression 
profiles), processed data is displayed intuitively on the graphical user interface, which is 
equipped with various interactive objects such as charting facilities, buttons, drop-down 
menus and user input/output dialogues. The interface is also equipped with a function to 
export processed data into Microsoft excel for further scrutiny and use. 
 
5.2.1 System Architecture 
MicroPath carries out meta-profiling of multiple gene expression datasets using two different 
approaches. Firstly, the intersection of common genes is identified across n number of 
expression profiles, which is then plotted graphically using a simple number crunching 
exercise. The second approach applies to a situation where an attempt to identify common 
genes across n number of expression profiles using the aforementioned approach fails due to 
the absence of common genes across all datasets (this situation is especially common when a 
  
107 
 
large number of expression profiles are compared, which reduces the probability of finding a 
common gene amongst them). Consequently, MicroPath applies the permutations and 
combinations mathematical principle to solve this problem (refer to implementation of meta-
analysis strategy below for details). Once the intersection of a set of common genes has been 
identified and subsequently displayed on the interface (using either of the above methods), 
the next stage in the analysis is to extract patterns from the intersection in order to identify 
common genes that are being expressed in accordance with the biological question. 
MicroPath offers a semi-automated graph-based approach to achieve this as well as classical 
statistics to identify the overall correlation of gene expression. Finally, co-expressed genes 
(common genes that are expressed in accordance to the relevant biological question) are 
mapped to all molecular pathways known to date in order to reveal their molecular 
dependencies (refer to Figure 5.1 for the complete system architecture). 
 
5.2.2 Implementation of Meta-analysis Strategy 
In theory, an intersection of a sub-set of common genes across multiple gene expression 
profiles should be easily attainable using simple number crunching methods of comparison. 
In practice, this is not always the case since the likelihood of identifying genes sharing 
common accession identifiers decreases as the number of profiles to compare increases. This 
inverse relationship makes sense both mathematically and biologically. From a biological 
perspective, regulatory signatures tend to be diluted over entire datasets and as a result, only a 
proportion of the total number of profiles to compare may actually share common genes. In 
such a scenario, using a simple method of comparison would break down at some point and 
no common genes would be reported to the user, although common genes may be present 
within n – 1 expression profiles. 
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Figure 5.1 Functions of MicroPath. Users are prompted to import up to 10 gene expression profiles, 
which are then compared using a direct comparison method. If this method yields zero common 
genes, MicroPath automatically attempts to identify an intersection of common genes by reducing the 
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search space to n – 1 datasets using permutations and combinations. This process is continued until at 
least 1 common gene is reported. Following this, users are provided with a function to search for 
expression patterns graphically and gene expression correlations are calculated statistically using the 
pearson’s correlation coefficient algorithm. Finally, co-expressed genes are mapped to all molecular 
pathways of KEGG in a high throughput fashion by automatically accessing its API via SOAP-Lite. 
 
To prevent potentially interesting biological findings to be hampered at this point in the 
analysis, we have applied the principle of mathematical combinations to the comparison of 
multiple gene expression profiles. All possible combinations of comparing n number of 
datasets with each other are firstly computed using the combination equation:  
 
This generates the total number of permutations of comparing datasets (Cr) for given values 
of n  (total number of datasets imported by user) and r (number of intended datasets used to 
search for common genes when zero common genes are reported across n datasets) (Table 
5.1). 
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Table 5.1 Multiple gene expression profile search strategy generated from applying the principle of 
permutations and combinations. 
Total number of 
expression datasets (n) 
Number of intended 
expression datasets to 
compare when 
comparing n datasets 
yields no results  (r) 
 
n - r 
Total number of 
combinations of r (Cr) 
10 9 1 10 
10 8 2 45 
10 7 3 120 
10 6 4 210 
10 5 5 252 
10 4 6 210 
10 3 7 120 
10 2 8 45 
9 8 1 9 
9 7 2 36 
9 6 3 84 
9 5 4 126 
9 4 5 126 
9 3 6 84 
9 2 7 36 
8 7 1 8 
8 6 2 28 
8 5 3 56 
8 4 4 70 
8 3 5 56 
8 2 6 28 
7 6 1 7 
7 5 2 21 
7 4 3 35 
7 3 4 35 
7 2 5 21 
6 5 1 6 
6 4 2 15 
6 3 3 20 
6 2 4 15 
5 4 1 5 
5 3 2 10 
5 2 3 10 
4 3 1 4 
4 2 2 6 
3 2 1 3 
 
Table 1: Multiple gene expression profile search strategy generated from applying the principle of 
permutations and combinations. The first column represents the total number of expression datasets, 
n, that users may import, which represents the search space. The second column represents r, the 
number of expression datasets to compare if zero common genes are reported to be matched across 
n datasets. The final column represents the total number of mathematical combinations possible for 
each given value of n and r. 
 
The first column represents the total number of expression datasets, n, that users may import (this is 
the search space). The second column represents, r, the number of expression datasets to compare if 
zero common genes are reported to be matched across n datasets. The final column represents the total 
number of mathematical combinations possible for each given value of n and r. 
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These combinations of datasets (Cr) are then used as a criterion to search for common genes 
across r number of gene expression profiles when comparing n number of datasets fail to 
yield any common genes. However in this scenario, n number of datasets is still used as the 
search space from which all possible combinations (Cr) of r datasets are compared to each 
other in order to increase the probability of finding a common gene. Once common genes 
have been identified using this method, MicroPath will report the results to the interface. 
 
5.2.3 Raw data analysis 
This function was specifically developed to facilitate the cross comparison of multiple gene 
expression profiles containing repeated genes. We implemented the Student’s t-test in order 
to firstly identify common genes across two datasets sharing an identical accession number. 
The subsequent step was designed to take each common gene (existing in both datasets) and 
use its repeated gene expression data points to compute the actual difference between their 
means in relation to the standard deviation. This pair-wise method of comparison was 
implemented to handle all possible comparisons for a maximum of 10 datasets and t-values 
for each common gene were calculated as follows: 
 
            Where             
  
Where s
2 
is the unbias estimator of the sample variance, n = number of replicates, 1 = sample 
data one and 2 = sample data two. Based on the recorded t-values, the degrees of freedom 
were computed using the Welch-Satterthwaite equation, which were in turn used to obtain p-
values: 
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5.2.4 Extracting Gene Expression Patterns Graphically and Statistically 
Following the identification of common genes across n datasets using either of the methods 
described earlier, the next stage in the analysis is to generate a graphical representation of this 
expression data from which biologically meaningful patterns can be extracted. Because 
signals pertaining to transcriptome states tend to be diluted over entire profiles, a specific 
criterion is required to narrow down the common genes of interest to include only those 
genes that are consistently regulated according to the biological question. The assumption we 
have made is that any given common gene across n datasets can exhibit one of three specific 
behaviours. It can either be consistently upregulated across all datasets, downregulated across 
all datasets and up or downregulated across all datasets. Based on the nature of the specific 
biological question, users can select the appropriate pattern from the options, which will 
result in a graphical display of those genes which satisfy the search criteria. Together with 
this faculty to graphically extract patterns for individual gene expression data points, 
MicroPath also implements the pearsons correlation coefficient statistical test in order to 
extract a global gene expression pattern existing between common genes relevant to two 
individual expression profiles. The correlations are calculated in a pair-wise manner until 
each expression data has been statistically compared to all other datasets within n, according 
to the pearsons correlation coefficient equation: 
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Each pair-wise score is then finally averaged in order to provide a global measure of 
correlation existing between n expression profiles. Scores are reported from -1 (perfect 
negative correlation) to +1 (perfect positive correlation). 
 
5.2.5 High Throughput Molecular Pathway Analysis 
To decipher molecular mechanisms fundamental to the researcher’s biological question, it is 
necessary to map common gene expression profiles of co-expressed genes to molecular 
pathways. This is because biological pathways reveal molecular dependencies that exist 
between genes by illustrating how they collaborate with one another when they participate in 
specific biological functions. Furthermore, pathways reveal various signalling cascades that 
play imperative roles in dictating these gene associations. In light of this, we have 
implemented Micropath to access the Application Programming Interface (API) of the 
molecular pathway database belonging to KEGG (Kanehisa et al., 2004) using SOAP-Lite in 
order to dynamically interact with the static pathway maps. Perl scripts were written for 
MicroPath to specifically 1) search for user’s co-expressed genes in all biological pathways, 
2) highlight genes on to pathways, and 3) return the results of the search to Micropath’s 
interface (i.e. URL’s of colour coded pathway maps) (Figure 5.2). Once MicroPath has 
searched for all of the user’s co-expressed genes in all of the molecular pathways, the URL of 
each pathway is displayed on the sub-interface. Clicking on these links will generate the 
specific KEGG pathway in HTML on which users co-expressed genes will be highlighted.  
In order to avoid redundancy issues, the URL for each pathway will highlight all co-
expressed genes that participate in a given pathway. Also, to help users identify biologically 
meaningful pathways relevant to their specific biological question, MicroPath will calculate 
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the number of genes identified in a given pathway and 1) express this as a percentage in 
relation to the total number of common genes from the intersection and 2) express this as a 
percentage in relation to the total number of genes belonging to that pathway. 
 
 
Figure 5.2: Flow diagram of how MicroPath carries out high throughput molecular pathway analysis 
by connecting to the API of KEGG.  
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5.2.6 Generating and Processing Gene Expression Datasets 
Gene expression datasets used for the purpose of this work were generated from our in-house 
microarray experiments as well as published datasets, where the fold change approach was 
used to select a set of differentially expressed genes from pre-processed data. Matchminer 
(Bussey et al., 2003) and the Synergizer (Berriz et al., 2008) tools were used to convert gene 
Hugo identifiers and long names into Genbank accession Id’s in order to ensure that the gene 
identifiers were of the same type across all datasets prior to comparison. Raw expression data 
was generated, filtered and normalised using GenePix pro 4.1 (www.axon.com) and Acuity 
4.0 (www.moleculardevices.com) software. Although we used cDNA microarray data for the 
purpose of demonstrating MicroPath’s capabilities, other data types generated from different 
platforms such as affymetrix can also be analysed provided Genbank accession identifiers are 
used to represent the genes.  
 
5.3 Results and Discussion 
Regardless of the biological question, a typical microarray experiment almost always results 
in the generation of a set of differentially expressed genes, which represents genes of most 
importance to the biologist. Therefore, by carrying out several biologically related microarray 
experiments, several sets of differentially expressed genes would be generated, which would 
need to be compared and mined efficiently in order to help answer the biological questions 
asked by the investigators from different research laboratories around the world. Employing 
manual methods of comparison in this situation would be very inefficient and infeasible. In 
light of this, to demonstrate the benefits that can be derived from analysing multiple gene 
expression profiles using MicroPath, we employed datasets generated from our in-house 
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microarray experiments as well as published data. The biological question related to these 
studies focussed on unravelling the underlying molecular mechanisms dictating immune 
tolerance by analysing the role of Egr-2 in implicating T-cell tolerance. Although the Early 
Growth Response gene (Egr-2) has been recently characterised as a candidate tolerance-
inducing transcription factor, which interacts with specific genes in order to induce the state 
of T-cell tolerance (Safford et al., 2005; Warner et al., 1999), the possibility of further 
putative unknown target genes exists that may be vital to the mechanism of tolerance. Hence, 
the biological purpose of our experiments was to attempt to identify such potentially 
important genes via the comparison of biologically related expression datasets using 
MicroPath.  
Data consisting of a set of differentially expressed genes generated from the comparison of 
tolerance Vs activated mice CD4+ T cells was obtained from the ArrayExpress website 
(accession number: e-mexp-283). The first in-house experiment aimed to generate 
differentially expressed genes from the comparison of an un-stimulated T cell line from 
which the Egr-2 gene had been knocked out and a wild type un-stimulated cell line. The 
second in-house experiment focussed on the comparison between an Egr-2 knock-out T cell 
line activated with CD3/CD28 for 6 hours and a wild type cell line also activated with 
CD3/CD28 for 6 hours. Results generated from these experiments were then compared with 
the aforementioned published tolerance data using MicroPath in order to understand the 
molecular mechanisms controlling immune tolerance. 
5.3.1 Comparison of Gene Expression Profiles related to Immune Tolerance 
The first step in the analysis was to subject the above-mentioned expression profiles to 
MicroPath in order to identify genes amongst them that had the same accession identifiers. 
Having done this, MicroPath identified 31 differentially expressed genes that were common 
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to all three expression datasets and generated a graph to delineate their expression values 
(Table 5.2, Figure 5.3). A simple number crunching exercise was used to perform this task 
since its use generated a reasonable number of common genes, which did not warrant the use 
of permutations and combinations to perform the search. The next step was to use these 31 
differentially expressed genes as a search space to determine those genes that have the 
potential to be co-expressed. In order to do this, we employed MicroPath’s graphical utility to 
extract gene expression patterns, which led to the identification of 6/31 genes that were found 
to be upregulated in tolerance Vs activated CD4+ T-cells and downregulated in both p-KOA0 
Vs WTA0 and p-KOA6 Vs WTA6 datasets (Table 5.2). The remaining 25 common 
differentially expressed genes were found to be highly and lowly expressed in tolerance and 
knock-out datasets respectively. Statistical analysis revealed an overall pearson’s correlation 
score of 0.109 from the pair-wise comparison of tolerance data with p-KOA0 Vs WTA0 and 
a score of -0.123 from the comparison of tolerance with p-KOA6 Vs WTA6. Furthermore, 
Reverse Transcriptase PCR experiments confirmed that 15 genes from our tolerance Vs 
activated data were found to be highly expressed in immune tolerance and from these 15 
genes, 8 were found to be common amongst all three expression profiles (Table 5.2).  
Because Egr-2 has been previously characterised and found to be highly upregulated in 
immune tolerance, these results generated from MicroPath are biologically significant 
because as expected, those genes that were highly expressed in our tolerance Vs activated 
datasets were found to be insignificantly expressed in our p-KOA6 Vs WTA6 and p-KOA0 
Vs WTA0 datasets (from which the Egr-2 gene was knocked out of the cell lines). Amongst 
these genes, Ap1s1, Shd, Surf6, Vil2, Lilrb4, Tbx21 and Pdcd1lg2 (Table 5.2) have been 
confirmed to be upregulated in the process of immune tolerance (Anderson et al., 2006), all 
of which were found to exhibit low expression values in our knock-out expression datasets. 
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This consistent gene expression pattern can be seen graphically in Figure 5.3. However, from 
the 31 interesting common genes, 16 were not confirmed to be involved in tolerance by RT-
PCR yet some of them also exhibited a coherent pattern of gene expression. For example, 
Ptma, Scd2, Hdac6, Pltp and Chka were all highly expressed in tolerance and conversely 
downregulated in both knock out datasets. There is a possibility that these genes may also be 
insignificantly expressed due to the absence of Egr-2. However, conducting RT-PCR for 
these specific genes would be required in order to confirm that their over-expression results 
in T-cell tolerance.  
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Table 5.2: Tabulated overview of gene accession ids, Hugo ids and fold change values belonging to 
31 common genes identified from the comparison of tolerant Vs activated CD4+ T cells, p-KOA0 Vs 
WTA0 and p-KOA6 Vs WTA6 expression datasets. 
Gene ID HUGO ID Fold Change (p-
KOA0 Vs WTA0) 
Fold Change (p-
KOA6 Vs WTA6) 
Fold Change 
(Tolerance Vs 
activated) 
NM_007381 Acadl 0.371336 0.624525 6.373 
NM_007457 Ap1s1 * 0.542474 0.31525 4.965 
NM_007664 Cdh2 0.243646 -0.7999 1.658 
NM_008205 H2-M9 -0.08048 0.116434 2.857 
NM_008972 Ptma -1.31334 -0.46688 5.42 
NM_009128 Scd2 -0.18816 -0.39366 4.552 
NM_009168 Shd * -0.17495 -0.53582 2.838 
NM_009298 Surf6 * 0.272072 0.126301 4.365 
NM_009465 Axl 0.149539 1.475806 3.836 
NM_009510 Vil2 * -0.49824 0.319645 3.151 
NM_010102 Edg6 0.313489 0.132689 1.573 
NM_010413 Hdac6 -0.90335 -0.8226 4.745 
NM_010548 Il10 * 3.083863 1.660739 3.521 
NM_010638 Bteb1 0.024803 -0.42533 1.613 
NM_011125 Pltp -0.5354 -0.71558 4.363 
NM_011620 Tnnt3 -0.61646 0.035844 1.665 
NM_011696 Vdac3 -0.98084 0.191964 4.701 
NM_011705 Vrk1 0.466922 -0.34601 2.032 
NM_013488 Cd4 0.584494 0.420277 4.905 
NM_013490 Chka -2.13728 -0.69458 5.677 
NM_013532 Lilrb4 * 0.792335 1.110898 2.111 
NM_013615 Odf2 2.776384 3.004449 4.809 
NM_013814 Galnt1 -0.47752 0.500297 2.246 
NM_013866 Zfp385 0.118995 0.428591 1.664 
NM_016772 Ech1 -0.0666 0.053081 4.284 
NM_019507 Tbx21 * 0.124767 -0.32731 1.595 
NM_019561 Ensa 0.778767 -0.44703 1.718 
NM_019777 Ikbke 0.291602 -0.00772 1.609 
NM_020027 Bat2 0.291219 -0.23966 5.091 
NM_021396 Pdcd1lg2 * 1.140087 0.079182 3.921 
NM_021538 Cope 0.154049 0.264541 2.035 
 
Table 2: Tabulated overview of Gene accession ids, Hugo ids and fold change values belonging to 31 
common genes identified from the comparison of tolerant Vs activated CD4+ T cells, p-KOA0 Vs 
WTA0 and p-KOA6 Vs WTA6 expression datasets. Entries highlighted in bold represent genes that 
were found to be up-regulated in tolerance Vs activated CD4+ T cells and down-regulated in both p-
KOA0 Vs WTA0 and p-KOA6 Vs WTA6 datasets. Entries with * represent genes that have been 
confirmed to be highly expressed in tolerance by RT-PCR. 
 
Entries highlighted in bold represent genes that were found to be up-regulated in tolerance Vs 
activated CD4+ T cells and down-regulated in both p-KOA0 Vs WTA0 and p-KOA6 Vs WTA6 
datasets. Entries with * represent genes that have been confirmed to be highly expressed in tolerance 
by RT-PCR. 
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Figure 5.3: A preliminary graphical overview of common interesting genes generated from the 
comparison of tolerant Vs activated CD4+ T cells (green), p-KOA0 Vs WTA0 (red) and p-KOA6 Vs 
WTA6 (blue) expression datasets. It can be seen that genes that are highly expressed in tolerance 
appear to be expressed poorly in the knock-out datasets. This pattern is consistent throughout the 31 
gene expression data points.  
 
5.3.2 Deciphering gene regulatory networks of co-expressed genes via high throughput 
molecular pathway analysis 
The final stage of the analysis entails using MicroPath’s function to connect to the 
Application Programming Interface (API) of KEGG via SOAP-Lite in order to carry out high 
throughput molecular pathway analysis. Therefore, for this stage in the analysis, we used 
MicroPath to map 31 of our co-expressed interesting genes to KEGG pathways and from 
these 31 genes, 14/31 were identified in a total of 31 molecular pathways (Table 5.3). 
Interestingly, several of these pathways were related to the study of immunology and 
illustrated biological networks such as MapKinase, Jak-Stat, T-cell receptor signalling and 
Cytokine-cytokine interactions. More specifically, the Pdcd1lg2 gene (accession id: 
NM_021396) was identified in the Cell Adhesion Molecules (CAM) pathway (Table 5.3) and 
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studies have confirmed that the over-expression of Pdcd1lg2 has resulted in consistently low 
levels of Interleukin-2 (IL-2) in naive CD4(+) T-cells (Kuipers et al., 2006). Further studies 
have correlated the over-expression of this gene to the negative regulation of T-cell 
activation. In one particular study, PDL2 (Pdcd1lg2) deficient mice were created in order to 
characterise the function of this gene in T-cell activation and tolerance, and results generated 
from this study suggested that Antigen-presenting cells from PDL2-deficient mice were 
found to be more potent in activating T-cells in vitro when compared to the wild-type 
counterparts (Zhang et al., 2006). These findings are conclusive and correlate well with the 
results generated from our in-house microarray experiments because using MicroPath to 
compare all three of our datasets followed by extracting gene expression patterns from them 
resulted in an important finding that Pdcd1lg2 was not only found to be over-expressed in 
tolerance (fold change of 3.921), but it was also under-expressed in our KOA0 Vs WTA0 and 
KOA6 Vs WTA6 knock-out datasets (with a fold change of 1.140 and 0.079 respectively) 
(Table 5.2). This particular finding is in agreement with the aforementioned studies, 
concluding that Pdcd1lg2 has a negative inhibitory role towards the process of T-cell 
activation. In addition, molecular pathway analysis of the Interleukin-10 (IL-10) gene using 
MicroPath identified its role in the Cytokine-cytokine interaction, Jak-STAT and T-cell 
receptor signalling pathways; all three of which are important immunological pathways. IL-
10 is a well known cytokine, which has previously been shown to successfully induce 
immune tolerance in Dendritic Cells (Li et al., 2007). Results generated from MicroPath 
revealed that IL-10 was highly expressed in our tolerance data with a fold change of 3.521, 
which was found to be expressed lower in our KOA0 Vs WTA0 profile (fold change: 3.084). 
Interestingly, following activated with CD3/CD28 for 6 hours, its expression dropped 
significantly to 1.66, perhaps attributable to the absence of Egr-2. Likewise, other genes from 
the 31 co-expressed interesting genes show similar patterns of expression and perhaps may be 
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candidate genes for Egr-2 mediated T-cell tolerance. However, this is yet to be confirmed by 
publications. Finally, the pathway analysis function of MicroPath was used to calculate the 
percentage of genes identified in each pathway in relation to 1) the intersection of common 
genes and 2) the total number of genes comprising each pathway. From the results, the Cell 
Adhesion Molecules (CAM) pathway was particularly significant since 12.91% of the overall 
pathway was affected by 6.84% of genes common to all 3 expression profiles (Table 5.4).  
 
Table 5.3: Tabulated data generated from high throughput molecular pathway analysis of co-
regulated genes. 14/31 common interesting genes were identified in a total of 31 molecular pathway 
maps of KEGG. 
 
GenBank 
Accession 
ID 
HUGO 
ID 
Pathway 
ID 
Total No 
of 
pathways 
GenBank 
Accession 
ID 
HUGO ID Pathway 
ID 
Total No 
of 
pathways 
 
 
 
NM_007381  
 
Acadl mmu00071  
mmu00280  
mmu00410 
mmu00640  
mmu03320  
 
5 
 
NM_009510   
 
Vil2 mmu04670 
mmu04810  
 
2 
 
NM_007664   Cdh2 mmu04514   1 
 
NM_008205   H2-M9 mmu04514 
mmu04612 
mmu04940  
 
3 
 
NM_013488   Cd4 mmu04514 
mmu04612 
mmu04640 
mmu04660 
 
4 
 
NM_013814   Galnt1 mmu00512 
mmu01030  
 
2 
 
NM_011696   Vdac3 mmu04020 1 NM_019777   Ikbke mmu04010 
mmu04620 
2 
 
NM_011125   Pltp   mmu03320   1 
 
NM_010102   Edg6 mmu04080   1 
 
NM_016772   Ech1 mmu00350 
mmu00362 
mmu00628  
 
3 
 
NM_021396 Pdcd1lg2 mmu04514 1 
 
NM_010548   Il10 mmu04060 
mmu04630 
mmu04660  
 
3 
 
NM_013652   Ccl4 mmu04060 
mmu04620  
 
2 
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Table 5.4: Results generated from pathway analysis showing the extent to which each pathway is 
affected by common genes from the intersection. The percentages reflect the proportion of common 
genes that contribute towards controlling the proportion of each pathway.  
 
Pathway ID Pathway Name GenBank 
Accession ID 
Result from Analysis 
 
mmu00071 
Fatty Acid 
Metabolism 
NM_007381  
 
3.26% of genes contribute 8.45% role in 
pathway 
mmu00280 Valine, leucine 
and isoleucine 
degradation 
NM_007381  
 
3.26% of genes contribute 2.73% role in 
pathway 
mmu00410 
 
Beta Alanine 
Metabolism 
NM_007381  
 
3.26% of genes contribute 7.14% role in 
pathway 
mmu00640 Propanoate 
Metabolism 
NM_007381  
 
3.26% of genes contribute 5.88% role in 
pathway 
mmu03320 PPAR Signalling 
Pathway 
NM_007381 3.26% of genes contribute 1.92% role in 
pathway 
mmu04514 Cell Adhesion 
Molecules 
NM_007664   
NM_008205   
NM_013488  
NM_021396 
12.91% of genes contribute 6.84 % role in 
pathway 
mmu04612 Antigen Processing 
& Presentation 
NM_013488 3.26% of genes contribute 2.44% role in 
pathway 
mmu04640 Hematopoietic Cell 
Lineage 
NM_013488   3.26% of genes contribute 0.76 % role in 
pathway 
mmu04660 
 
T Cell Receptor 
Signalling Pathway 
NM_013488   
NM_010548   
 
6.45 % of genes contribute 3.33 % role in 
pathway 
mmu04020 Calcium Signalling 
Pathway 
NM_011696 3.26% of genes contribute 2.33 % role in 
pathway 
mmu00350 
 
Tyrosine 
Metabolism 
NM_016772 
 
3.26% of genes contribute 2.17 % role in 
pathway 
mmu04060 
 
Cytokine-cytokine 
receptor interaction 
NM_010548 
NM_013652     
6.45 % of genes contribute 0.73 % role in 
pathway 
mmu04630 
 
JAK-STAT 
Signalling Pathway 
NM_010548 
 
3.26% of genes contribute 3.85 % role in 
pathway 
mmu04670 
 
Leukocyte 
Transendothelial 
Migration 
NM_009510   
 
3.26% of genes contribute 1.25 % role in 
pathway 
mmu04810 Regulation of Actin 
Cytoskeleton 
NM_009510   
 
3.26% of genes contribute 1.47 % role in 
pathway 
mmu04940 Type I Diabetes 
Mellitus 
NM_008205   3.26% of genes contribute 4.35 % role in 
pathway 
mmu00512 
 
O-Glycan 
Biosynthesis 
NM_013814   3.26% of genes contribute 10 % role in 
pathway 
mmu04010 
 
MAPK Signalling 
Pathway 
NM_019777   3.26% of genes contribute 0.83 % role in 
pathway 
mmu04620 Toll-Like Receptor 
Signalling Pathway 
NM_019777  
NM_013652    
6.45% of genes contribute 1.32 % role in 
pathway 
mmu04080 Neuroactive 
Ligand-Receptor 
Interaction 
NM_010102   3.26% of genes contribute 1.15 % role in 
pathway 
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The fundamental strength of MicroPath stems from the implementation of a novel search 
strategy for the comparison of multiple gene expression profiles. Although there are a few 
software that cater for multiple gene expression comparison, there is currently no software 
that searches for common genes beyond simple number crunching methods of comparison 
(Table 5.5). Just because a direct comparison of a given number of datasets may not yield any 
common genes, it does not mean that the analysis should end here since there is a potential to 
identify common genes across n – 1 profiles. MicroPath ensures that such genes are 
identified, which current software would overlook. When coupled with other important 
functions such as pattern extraction and pathway analysis, it becomes apparent that 
MicroPath would offer valuable assistance to biologists wanting to decipher their high 
throughput data. 
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Table 5.5: Functional comparison of MicroPath to similar software packages and applications. 
 
Function 
 
 
MicroPath 
 
 
EXPANDER 
 
INCLUSIVE 
 
Pathway 
Studio 
 
KEGG 
 
BioCarta 
 
 
 
MaXlab 
 
Suitable for high 
throughput data 
analysis 
 
YES 
 
YES 
 
YES 
 
YES 
 
NO 
 
NO 
 
YES 
Suitable for 
comparing multiple 
gene expression 
profiles 
YES YES NO YES NO NO YES 
Implementation of 
efficient algorithm to 
search for common 
genes from n – 1 
datasets 
YES NO NO NO NO NO NO 
Graphical 
representation of gene  
expression values 
from multiple datasets 
YES NO NO NO NO NO YES 
Pattern extraction 
from Graph data 
YES NO NO NO NO NO NO 
Construction of 
pathway maps 
 
YES 
 
NO 
 
NO 
 
YES 
 
YES 
 
YES 
 
NO 
Mapping gene 
expression data to 
pathway maps 
 
YES 
 
NO 
 
NO 
 
YES 
 
 
NO 
 
NO 
 
NO 
User interactive 
software (S) or 
Database (D) 
 
S 
 
S 
 
 
S 
 
S 
 
D 
 
D 
 
S 
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5.4 Conclusion 
In this chapter, we have illustrated the potential benefits that can be derived from using 
MicroPath for the analysis of multiple gene expression profiles. Each function of the software 
has been developed to streamline the overall analysis pipeline, providing users with a 
walkthrough of how their data is biologically deciphered. Here, we have applied to our 
software, microarray datasets generated from different laboratories pertaining to the 
molecular mechanisms underlying immune tolerance. However, MicroPath is capable of 
analysing data for any given biological question, whether the datasets are taken from public 
repositories such as ArrayExpress or generated from in-house microarray experiments. We 
believe that its faculty to use both number crunching and permutations and combinations as 
the search strategy to identify the intersection of common genes, coupled with its function to 
extract gene expression patterns graphically and statistically makes this a attractive software 
for biologists to use. Finally, its ability to carry out live streaming of mapping genes to 
biological pathways makes it a useful tool for the automation of multiple gene expression 
analysis. 
5.5 Future Work 
Chapters 3 and 4 discussed the application of generating contingency tables and subsequently 
using them for the Fisher’s exact test in order to generate P values in the context of 
transcription factor binding motif enrichment analysis. However, this approach can also be 
employed for the purpose of identifying molecular pathways that are enriched with genes 
from the user’s expression data. The principle is the same as TFBM enrichment analysis, 
except that for MicroPath, a contingency table will be generated for each KEGG pathway that 
contains common genes from the user’s datasets. Following this, the Fishers exact test will be 
applied to generate a P value for each pathway to discern KEGG pathways that are 
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significantly enriched with common genes from the user’s datasets in relation to the entire 
genome.  
 
For this future work, a contingency table for each KEGG pathway will first need to be 
derived as follows: 
 
 
Chosen Not Chosen  Total 
  TFBM  a  b       a + b 
  Absent  c  d       c + d 
  Totals  a + c  b + d        n 
Where: a = No of common genes in user’s gene lists found in KEGG 
pathway (chosen from gene list) 
b = No of genes in the genome found in KEGG pathway minus a (Not 
chosen from gene list) 
c = No of common genes in user’s gene lists not found in KEGG pathway 
(chosen from gene list) 
d = Total no of genes in genome – (a + b + c) 
n = Sum of each total (Grand total) 
 
 
These contingency tables will reflect the degree of enrichment of a given KEGG pathway in 
the user’s sets of differentially expressed genes (common genes) relative to the entire 
genome. Once contingency tables have been generated for all consensus binding sites, 
Micropath will then apply the Fisher’s exact test to compute P values for each KEGG 
pathway from their contingency tables using the following hypergeometric distribution: 
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Where  = binomial coefficient and ! = factorial operator 
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Chapter 6 
Conclusions and Future Work 
 
6.1 Introduction 
The reductionist approach to biological research has proven to be imperative in developing 
our basic but necessary understanding of living systems. Studying and subsequently 
identifying the individual components (such as genes, proteins and metabolites) that regulate 
specific physiological phenomenon (for instance, metabolic activity, response to external 
stimuli etc) has no doubt proven to be an effective strategy in elucidating key molecular 
components of living systems, leading to a variety of important applications in agriculture 
and medicine (Aggarwal & Lee, 2003). However, it has become clear now that in order to 
fully understand the behaviour of biological systems, we have to look beyond isolated parts 
of an organism. In other words, scrutinizing the genome or the proteome autonomously does 
not warrant a complete understanding of the biological system until and unless they are 
examined in the context of the organism as a whole unit. This is the point where systems 
biology becomes an extremely important consideration. 
It is precisely the aforementioned reasons that have motivated systems biology, which has 
resulted in a paradigm shift from a reductionist approach to an integrative one. This is indeed 
an effective strategy since it encourages a scrutiny of the structure and dynamics of cellular 
function in the context of the organism as a whole rather than examining the characteristics of 
isolated parts of the cell or organism (Kitano, 2002). The importance of systems biology 
becomes apparent when we examine the current situation with drug discovery. Despite the 
fact that an astronomical amount of investment has taken place over the past 20 years towards 
6 
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screening technologies and genomics, the truth remains that the costs associated with new 
drug discovery continue to rise while approval rates fall. This is largely attributable to the fact 
that merely knowing a target is not sufficient to warrant an understanding of what the target 
does, let alone knowing the effects of a chemical inhibitor in diverse disease settings 
(Butcher, 2004). It is hence not surprising that approval rates are continuously falling in the 
milieu of drug development programs. After all, before we can truly understand the 
physiological implications of a particular drug, we must be in a position to understand how 
the target biological system functions as a synchronized unit. This is why bioinformatics is 
becoming a necessity in the study of biological sciences due to the fact that the latter has 
become highly reliant on informatics, mathematics, computer algorithms, software 
development and statistics. This especially holds true when we consider the marriage 
between high throughput technologies such as microarrays with systems biology. 
On one hand we have a high throughput technology offering a platform to measure mRNA 
transcript levels for entire genomes simultaneously in a cost effective and efficient fashion, 
and on the other hand, we have a interdisciplinary science specializing in the application of 
mathematics, computer science and biology with the fundamental purpose of unravelling the 
underlying functional dynamics of the cell in the perspective of the entire organism. The 
potential strength of this collaboration is based on a common goal; to understand cellular and 
molecular function in the context of the organism as a whole. In theory, the possibilities are 
endless. In practice however, systems biology is still at its infancy and consequently, there is 
much to be desired. 
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It is this exact need to better apply systems biology to solve biological problems that 
motivated the research presented in this thesis. We began systematically by firstly developing 
BiSAn (Chapter 3), which when applied to a set of microarray data proved to show an 
important capability to compute binding affinities of several Transcription Factors in relation 
to promoter regions belonging to the genes of interest. The second step was to move towards 
an integrative approach, which motivated the development of Genome Interactions Analyzer 
(GIA) (Chapter 4). By integrating the analysis of transcription factors, Protein-protein 
interactions and molecular pathways in an attempt to decipher gene expression data in a 
systems biology context, we were able to demonstrate that such an approach can be effective 
in helping biologists to elucidate molecular mechanisms underlying a given biological 
question. The most notable contribution however was the development of MicroPath 
(Chapter 5), which emphasized on the need to analyze multiple biologically related gene 
expression datasets in a systems biology context. The result of this is that a novel rationale 
has emerged, which could have putative benefits in treating disease. Before this rationale is 
explained, some of the weaknesses of this research need to be addressed. 
 
6.2 Weaknesses 
The fundamental weakness of the research presented in this thesis is based on its potential to 
be scalable. The first challenge is directly related to the limitation of MicroPath. Although the 
Permutation and Combination algorithm underlying MicroPath is important in the sense that 
it increases the probability of finding a common gene across multiple gene expression 
datasets, in its current state it is only able to cater for the comparison of 10 gene expression 
datasets. In light of this, the algorithm needs to be optimized so that it can handle the cross 
comparison of a much larger number of datasets. 
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The second limitation of this research is that the several different functions developed, 
namely transcription factor binding site analysis and molecular pathway analysis, need to be 
more tightly integrated. Currently, the software tools developed during the course of this 
research exist as autonomous pipelines. Because each of our software have different 
functionalities, it is imperative for these key functions to be more tightly integrated together 
in a scalable fashion to generate an overall pipeline that would apply a true systems biology 
method to the analysis of gene expression profiles.  
 
What this effectively means is that MicroPath needs to be scaled so that it can handle a much 
larger number of expression dataset comparisons coupled with a need to integrate it with 
TFBM analysis from BiSAn. Furthermore, although the current state of Micropath allows it 
to map 10 expression profiles to all molecular pathways known to date, this function needs to 
be optimized to cater for a much larger number of datasets. Recognizing these limitations and 
weaknesses, a rationale is proposed in the following section of this chapter  
 
6.3 A rationale for treating disease - Future Work 
It cannot be denied that high throughput technologies such as microarrays have rapidly 
gained popularity at a global scale due to the prospect of quantifying gene expression in a 
high throughput fashion and subsequently identifying previously unknown transcriptome 
states. For this reason, gene expression data pertaining to various different biological 
questions are being rapidly generated by scientists worldwide and such datasets are now 
readily accessible through public repositories such as ArrayExpress (Sarkans et al., 2005) and 
the Gene Expression Omnibus (GEO) (Barrett et al., 2006). This has motivated biologists to 
utilise these sets of data in an attempt to investigate common regulatory signatures that can be 
potentially found across multiple experiments sharing a similar biological theme. One of the 
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most common methods of comparison is based on the assumption that genes across different 
biological conditions having similar expression patterns are likely to be involved in the same 
biological process (Rhodes et al., 2004) and hence, may share the same regulatory signatures. 
Using this method of comparison, which is one of the most successful methods to date, 
coupled with the availability of publicly accessible gene expression data repositories, 
biologists now have the opportunity to answer complex biological questions pertaining to 
biological phenomena underlying various different disease states. Chapter 5 demonstrated the 
works of Khan et al., (In Press) illustrating a novel algorithm that applied the principle of 
Permutations and Combinations to increase the probability of identifying common genes 
across multiple expression profiles. The need for optimizing this algorithm has been 
explained above and now, the importance of this optimization will be discussed. 
 
Gene Expression Omnibus (GEO) and ArrayExpress contain hundreds and thousands of 
expression profiles relevant to a variety of different biological questions underlying many 
diseases such as Cancer. A common complaint is that because such data repositories hold 
vast volumes of microarray data in different file formats, it becomes problematic to facilitate 
their comparisons due to heterogeneity. The second problem is that if hundreds or thousands 
of datasets are compared, chances of finding a common gene identifier across all datasets 
would be very low. The first problem can be tackled by segregating expression profiles 
according to the format they subscribe to. This would create sets of homogeneous profiles, 
which can be compared with ease. The solution to the second problem lies in the optimization 
of MicroPath due to its ability to search for common gene identifiers across n – 1 profiles, 
when a simple number crunching method of comparison fails to yield any results. Coupled 
with the algorithm underlying BiSAn, and optimization of the High Throughput pathway 
analysis function, it becomes apparent that this rationale could lead to some important 
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biological findings at the disease level. For instance if common genes identified across 
hundreds of different expression profiles pertinent to a certain type of Cancer exhibit similar 
expression patterns, it may constitute important in silico findings because there may be 
candidate genes present within the intersection. Such genes could then be investigated at the 
in vivo level, where certain candidate oncogenes for example could be silenced in 
tumerogenic mice to see the observed effects. 
 
We are faced with a situation where we have vast amounts of biological data available to 
decipher, but not enough focus is being shifted to it. The answer to several biological 
questions lies in the data itself but sophisticated algorithms and automated software pipelines 
are required to effectively mine them in a true systems biology context. 
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Appendix 
 
 
 
 
  
 
 
The magnitude of code written for developing the software presented in this thesis is too vast 
to document. Therefore, only specific key sections of the code will be shown here, mainly 
relevant to some of the algorithms developed for the purpose of this research. 
 
 
 
The following code was written in Perl to facilitate high throughput Transcription Factor 
Binding Motif (TFBM) detection for microarray data. This code pertains to the underlying 
algorithm explained in Chapter 3 of this thesis. 
 
#!/usr/bin/perl 
use strict; 
use Win32::OLE qw(in with); 
use Win32::OLE::Const 'Microsoft Excel'; 
 
open(INFILE, "<C:/Perl/eg/userdata.txt") or die ("couldn't open the file 
userdata.txt: $!\n"); 
my @udata = <INFILE>; 
close(INFILE); 
 
my $promoter; 
my @temp=(); 
my @tempp=(); 
 
my $count; 
my $coun; 
my $cou; 
 
my $jasparid; 
my $tfname; 
my $class; 
my $species; 
my $sysgroup; 
my $length; 
A. 
Code 
A1. High throughput TFBM Detection 
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my $max; 
 
my @digit=(); 
my $digit; 
my $marks; 
my $coll; 
my @scorearray=(); 
my $scorearray; 
my $percent; 
my $totpercent; 
my @percentarray=(); 
my $percentarray; 
my $kount; 
my @result=(); 
my $result; 
 
my %final=(); 
my $final; 
foreach my $udata(@udata) 
{ 
chomp($udata); 
$count=0; 
$cou=0; 
my @array1=split(/\s+/, $udata); 
my $array1; 
my $geneid=$array1[0]; 
my $genename=$array1[1]; 
 
print("--------------------------------------------------------------------
------------\n"); 
print("    $geneid\t$genename\n\n"); 
print("--------------------------------------------------------------------
------------\n\n"); 
 
 
open(INFILE, "<C:/promoterid.txt") or die("couldn't open the file 
promoterid.txt: $!\n"); 
my @promoterids=<INFILE>; 
close(INFILE); 
 
 
my $promoterids; 
my $promoterseqs; 
 
for my $i(0..$#promoterids) 
{ 
chomp($promoterids[$i]); 
 
if($geneid =~ m/$promoterids[$i]/i) 
{ 
 
 
$cou++; 
 
$Win32::OLE::Warn = 3; 
 
my $Excel = Win32::OLE->new('Excel.Application', 'Quit'); 
 
my $Book = $Excel->Workbooks->Open("C:/promoterseqs.xls"); 
my $Sheet = $Book->Worksheets(1); 
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$promoter=$Sheet->Cells($i+1, 1)->{'Value'}; 
} 
} 
if($cou==0) 
{ 
print("The gene was not found in the promoters database.\n\n"); 
print("--------------------------------------------------------------------
-----------\n"); 
print("--------------------------------------------------------------------
-----------\n\n"); 
 
goto end; 
} 
 
 
$Win32::OLE::Warn = 3; 
 
my $Excel = Win32::OLE->new('Excel.Application', 'Quit'); 
 
my $Book = $Excel->Workbooks->Open("C:/mouse.xls"); 
my $Sheet = $Book->Worksheets(1); 
 
for(my $row=1;$row<114;$row+=5) 
 { 
 
$kount=0; 
$coun=0; 
 my $pattern = $Sheet->Cells($row, 2)->{'Value'}; 
 
 
if($promoter =~ m/$pattern/gi) 
  { 
$coun++; 
$count++; 
my $endpos = pos($promoter); 
 
 
$jasparid=$Sheet->Cells($row, 1)->{'Value'}; 
$tfname=$Sheet->Cells($row, 3)->{'Value'}; 
$class=$Sheet->Cells($row, 4)->{'Value'}; 
$species=$Sheet->Cells($row, 5)->{'Value'}; 
$sysgroup=$Sheet->Cells($row, 6)->{'Value'}; 
$length=$Sheet->Cells($row, 7)->{'Value'}; 
$max=$Sheet->Cells($row, 8)->{'Value'}; 
 
 
my $startpos=($endpos+1)-$length; 
my $lastpos=$endpos; 
 
my $consensus = substr($promoter, ($startpos-1), $length); 
 
push(@temp, $consensus, $startpos, $lastpos); 
 
} 
if($coun==0) 
{ 
goto nex; 
} 
push(@tempp, $tfname, $class, $species, $sysgroup, $jasparid); 
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my $temp; 
my $tempp; 
 
print("------------------------------------\n"); 
print("Transcription Factor Name:\t$tempp[0]\n\n"); 
print("Transcription Factor Class:\t$tempp[1]\n\n"); 
print("Species:\t\t$tempp[2]\n\n"); 
print("Sysgroup:\t\t$tempp[3]\n\n"); 
my $size=@temp; 
for (my $k=0;$k<=$size-1;$k+=3) 
{ 
$coll=10; 
$kount++; 
print("Transcription Factor binding site Sequence :$temp[$k]\t"); 
@digit = split(//, $temp[$k]); 
foreach $digit (@digit) 
{ 
if($digit =~ m/A/) 
{ 
$marks = $Sheet->Cells($row, $coll)->{'Value'}; 
push(@scorearray, $marks); 
} 
if($digit =~ m/C/) 
{ 
$marks = $Sheet->Cells($row+1, $coll)->{'Value'}; 
push(@scorearray, $marks); 
} 
if($digit =~ m/G/) 
{ 
$marks = $Sheet->Cells($row+2, $coll)->{'Value'}; 
push(@scorearray, $marks); 
} 
if($digit =~ m/T/) 
{ 
$marks = $Sheet->Cells($row+3, $coll)->{'Value'}; 
push(@scorearray, $marks); 
} 
$coll++; 
} 
@digit=(); 
my $tem=0; 
foreach $scorearray(@scorearray) 
{ 
$tem = $tem+$scorearray; 
} 
@scorearray = (); 
$percent = ($tem/($length*$max))*100; 
$totpercent = ($tem/(10.09*29.35))*100; 
push(@percentarray, $totpercent); 
print("Start position in promoter: \"$temp[$k+1]\"\t"); 
print("End position : \"$temp[$k+2]\"\n\n\n"); 
my $fpercent = sprintf("%.2f", $percent); 
print("Possibility of binding of the Transcription Factor $tempp[0] at the 
above positions of promoter site of the gene $genename ($geneid) is : 
$fpercent\%\n\n\n"); 
 
} 
 
my $url= "http://jaspar.genereg.net/cgi-bin/jaspar_db.pl?ID=" . $tempp[4] . 
"\&rm=present\&db=0"; 
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print("The URL to the JASPAR database for this Transcription Factor:\n\n 
$url\n"); 
print("\n\n\n"); 
my $whole=0; 
foreach $percentarray(@percentarray) 
{ 
$whole = $whole+$percentarray; 
} 
@percentarray = (); 
my $overall = ($whole/($kount*100))*100; 
my $strin = ($tempp[0]."\t".$kount."\t".$url); 
push(@result, $strin, $overall); 
 
@temp=(); 
@tempp=(); 
  next: 
} 
if($count>0) 
{ 
for (my $l=0;$l<=$#result;$l+=2) 
 { 
my $fresult = sprintf("%.2f", $result[$l+1]); 
$final{$result[$l]} = $fresult; 
} 
print("--------------------------------------------------------------------
-----------\n\n"); 
print("Order of Transcription factors based on their possible binding 
affinity to this gene.\n\n"); 
print("--------------------------------------------------------------------
-----------\n\n"); 
print("TFname\tNo.of binding sites\tJASPAR link\tBinding affinity 
percentage\n\n"); 
print("--------------------------------------------------------------------
-----------\n\n"); 
foreach my $value (sort {$final{$b} cmp $final{$a} } 
 keys %final) 
{ 
    print "$value\t $final{$value}\%\n\n"; 
} 
%final=(); 
print("--------------------------------------------------------------------
-----------\n"); 
print("--------------------------------------------------------------------
-----------\n"); 
print("\n\n"); 
goto end; 
} 
print("No Transcription Factor was found for this gene.\n\n\n"); 
print("--------------------------------------------------------------------
------------\n"); 
print("--------------------------------------------------------------------
------------\n\n\n"); 
end: 
} 
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The following code was written to carry out TFBM enrichment analysis as a part of BiSAn: 
 
#!/usr/bin/perl 
 
use strict; 
use Win32::OLE qw(in with); 
use Win32::OLE::Const 'Microsoft Excel'; 
use Text::NSP::Measures::2D::Fisher2::right; 
 
 
my @promoterseqs = (); 
my @consensusseqs = (); 
 
 
my @geneids = (); 
my @genenames = (); 
 
my @userproms = (); 
 
my $count; 
my $kount; 
my $cou=1; 
 
my $promoterseqs; 
my $userproms; 
 
my $consensusid; 
my $consensusname; 
 
my $rightpvalue; 
my $errorCode; 
 
my $absenusers; 
 
my $check; 
my $checktwo; 
 
my $kou=0; 
 
my @array; 
my $array; 
 
my $size; 
my $notfound; 
 
 
open(INFILE, "<C:/userdata.txt") or die ("couldn't open the file 
userdata.txt: $!\n"); 
my @udata = <INFILE>; 
close(INFILE); 
 
foreach my $udata(@udata) 
{ 
 chomp($udata); 
 
A1.1 TFBM Enrichment Analysis 
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  @array = split(/\s+/, $udata); 
 
 
 
 chomp($array[0]); 
 
 chomp($array[1]); 
 
 push(@geneids, $array[0]); 
 
 push(@genenames, $array[1]); 
 
 
} 
 
 
open(INFILE, "<C:/promoterid.txt") or die("couldn't open the file 
promoterid.txt: $!\n"); 
 
my @promoterids = <INFILE>; 
 
close(INFILE); 
 
 
 foreach my $geneids(@geneids) 
 { 
  chomp($geneids); 
 
  for my $k(0..$#promoterids) 
  { 
   chomp($promoterids[$k]); 
 
   if($promoterids[$k] =~ m/$geneids/i) 
   { 
    $kou++; 
 
 
    $Win32::OLE::Warn = 3; 
 
    my $Excel = Win32::OLE->new('Excel.Application', 
'Quit'); 
 
    my $Book = $Excel->workbooks-
>open("C:/promoterseqs.xls"); 
 
    my $Sheet = $Book->worksheets(1); 
 
    my $prom = $Sheet->Cells($k+1, 1)->{'Value'}; 
 
    push(@userproms, $prom); 
 
    goto next; 
 
   } 
 
  } 
 
 
 next: 
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 } 
 
  print("\n\nPromoter sequences found from user's data = $kou\n\n"); 
 
  $size = @geneids; 
 
 $notfound = ($size-$kou); 
 
  print("Promoter sequences not found from user's data = 
$notfound\n\n"); 
 
 
 
$Win32::OLE::Warn = 3; 
 
 
my $Excel = Win32::OLE->new('Excel.Application', 'Quit'); 
 
 
my $Book = $Excel->Workbooks->open("C:/promoterseqs.xls"); 
 
my $Sheet = $Book->Worksheets(1); 
 
 
for my $i(1..18073) 
{ 
 
 my $promoter = $Sheet->Cells($i, 1)->{'Value'}; 
 
 push(@promoterseqs, $promoter); 
 
 
} 
 
 
$win32::OLE::Warn = 3; 
 
 
my $Excel = Win32::OLE->new('Excel.Application', 'Quit'); 
 
 
my $Book = $Excel->Workbooks->open("C:/mouse.xls"); 
 
my $Sheet = $Book->Worksheets(1); 
 
 
for(my $j=1;$j<114;$j+=5) 
{ 
 
 my $consensus = $Sheet->Cells($j, 2)->{'Value'}; 
 
 
 push(@consensusseqs, $consensus); 
 
 
} 
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foreach my $consensusseqs(@consensusseqs) 
{ 
 chomp($consensusseqs); 
 
 
 $count = 0; 
 
 
 
 
 foreach $promoterseqs(@promoterseqs) 
 { 
 
 
  chomp($promoterseqs); 
 
 if($promoterseqs =~ m/$consensusseqs/i) 
    { 
 
 
  $count++; 
 
 
    } 
 
 
 
 } 
 
 
 
  print("The consensus binding site $consensusseqs occurs $count times 
in the genome.\n\n"); 
 
 
 $kount = 0; 
 
 
 foreach $userproms(@userproms) 
 { 
 
 
  chomp($userproms); 
 
  if($userproms =~ m/$consensusseqs/i) 
  { 
 
   $kount++; 
 
 
  } 
 
 } 
 
 
 
 $win32::OLE::Warn = 3; 
 
 
my $Excel = Win32::OLE->new('Excel.Application', 'Quit'); 
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my $Book = $Excel->Workbooks->open("C:/mouse.xls"); 
 
my $Sheet = $Book->Worksheets(1); 
 
 
 $consensusid = $Sheet->Cells($cou, 1)->{'Value'}; 
 
 $consensusname = $Sheet->Cells($cou, 3)->{'Value'}; 
 
 
 $cou+=5; 
 
 
 print("This consensus binding site is found $kount times in the 
user's data.\n\n"); 
 
 
 $absenusers = ($kou-$kount); 
 
 my $second = ($count-$kount); 
 
 my $fourth = (18073-($kount+$absenusers+$second)); 
 
 
 
 my $npp = ($kount+$absenusers+$second+$fourth); 
 my $n1p = ($kount+$second); 
  my $np1 = ($kount+$absenusers); 
   my $n11 = $kount; 
 
  $rightpvalue = calculateStatistic( n11=>$n11, 
                                      n1p=>$n1p, 
                                      np1=>$np1, 
                                      npp=>$npp); 
 
 
 
 print ("$consensusid-($consensusname)-$consensusseqs\n\n 
 
  p-value = $rightpvalue\n\n 
  --------------------------------------------\n\n"); 
 
 
 
 
} 
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The following code was written in Perl to facilitate high throughput molecular pathway 
analysis of microarray data by connecting to the Application Programming Interface (API) of 
KEGG in a live fashion. This code is specific to Genbank Accession ID’s so the code picks 
up these ID’s from the users input file and searches for them in all of KEGG’s pathways. 
Where found, genes are highlighted on the pathways automatically. A detailed explanation of 
this function is explained in Chapter 4 of this thesis in the section pertaining to high 
throughput molecular pathway analysis. 
 
#!/usr/bin/perl -w 
open(FILE, "C:/mousekegg.txt"); 
my @array = <FILE>; 
print "\n\n"; 
print "                                  THE RESULTS    
 \n"; 
print "--------------------------------------------------------------------
---------------------------------------------------------------------------
-----------------"; 
my $count = 1; 
foreach my $array (@array) 
{print "\n\n\n$count ) the gene $count from the user's data:\n\n\n"; 
 $count++; 
 
chomp ($array); 
  my @temp = split (/\s+/, $array); 
  for(my $j=1;$j<=1;$j++) 
{ 
   my $key = $temp[0]; 
   print "\t$key\n"; 
   my $val = $temp[1]; 
 
  my $exprr = $temp[2]; 
print("HUGO name of the gene: $temp[1]\n\n"); 
 print("mean expression of the gene: $exprr\n\n"); 
 my @aaaa=split(//, $exprr); 
 my $express=$aaaa[0]; 
 
   if ($express eq "+") 
     { 
  print "upregulated\n\n"; 
 
     } 
    elsif ($express eq "-") 
  { print "downregulated\n\n"; 
A2. High throughput Molecular pathway analysis 
A2.1 Analyzing Genbank Accession Identifiers in KEGG pathways 
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  } 
use Data::Dumper; 
use SOAP::Lite +trace => [qw(debug)]; 
 
 
my $serv = SOAP::Lite ->service("http://soap.genome.jp/KEGG.wsdl"); 
my $result = $serv ->bconv("genbank:$key"); 
my $length = length($result); 
unless($length==0) 
{ 
 
my @tem = split(/\s+/, $result); 
 for(my $k=1;$k<=1;$k++) 
{ 
 my $id = $tem[1]; 
 
my $keggid = [$id]; 
 
  my $arrayRef = $serv ->get_pathways_by_genes([$id]); 
 
 
my $final = Dumper $arrayRef; 
 
 
my @hifi = split(/'/, $final); 
my $size = @hifi; 
 for(my $i=1;$i<$size;$i=$i+2) 
 
 { 
 my $keggpath = $hifi[$i]; 
 
 
 
 if ($express eq "+") 
 { 
 
 print "kegg pathway id is : $keggpath\n\n"; 
 
 
 
 
      my $fg_list= ['green']; 
   my $bg_list=['red']; 
my $extreme = $serv->get_html_of_colored_pathway_by_objects($keggpath, 
$keggid, $fg_list, $bg_list); 
 
print $extreme, "\n\n"; 
} 
elsif ($express eq "-") 
{ print "kegg pathway id is : $keggpath \n\n"; 
 
 $fg_list= ['red']; 
 $bg_list=['green']; 
 
 $extreme = $serv->get_html_of_colored_pathway_by_objects($keggpath, 
$keggid, $fg_list, $bg_list); 
 
print $extreme, "\n\n"; 
 
} 
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}goto outside; 
} 
} 
 
use Win32::OLE qw(in with); 
use Win32::OLE::Const 'Microsoft Excel'; 
 
$Win32::OLE::Warn = 3; 
 
 
my $Excel = Win32::OLE->new('Excel.Application', 'Quit'); 
 
 
my $Book = $Excel->Workbooks->Open("C:/MMU.xls"); 
 
 
my $Sheet = $Book->Worksheets(1); 
 
foreach my $row (1..4829) 
{ 
for (my $col=3;$col<=3;$col++) 
 { 
 
  next unless defined $Sheet->Cells($row,$col)->{'Value'}; 
  my $id = $Sheet->Cells($row, $col)->{'Value'}; 
 
  while ($id =~ m/$key/) 
      { 
 
    my $mainid=$id; 
    my $entrez = $Sheet->Cells($row,2)->{'Value'}; 
my $gene = $Sheet->Cells($row,1)->{'Value'}; 
 my $pathid = $Sheet->Cells($row,4)->{'Value'}; 
 my @pathway = split(/ /, $pathid); 
 
 
my $size = @pathway; 
 
for (my $i=0; $i<$size; $i++) 
{use SOAP::Lite +trace => [qw(debug)]; 
 
 
my $serv = SOAP::Lite ->service("http://soap.genome.jp/KEGG.wsdl"); 
if ($express eq "+") 
{ 
print "kegg pathway id is : $pathway[$i] \n\n"; 
my $keggid=["mmu:".$entrez]; 
my $keggpath = ("path:".$pathway[$i]); 
my $fg_list= ['green']; 
my $bg_list=['red']; 
my $result = $serv->get_html_of_colored_pathway_by_objects($keggpath, 
$keggid, $fg_list, $bg_list); 
print $result, "\n\n"; 
} 
elsif ($express eq "-") 
 { print "kegg pathway id is : $pathway[$i] \n\n"; 
 my $keggid=["mmu:".$entrez]; 
 my $keggpath = ("path:".$pathway[$i]); 
 my $fg_list= ['red']; 
 my $bg_list=['green']; 
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my $result = $serv->get_html_of_colored_pathway_by_objects($keggpath, 
$keggid, $fg_list, $bg_list); 
 
 print $result, "\n\n"; 
 } 
} 
  goto outside; 
 } 
  } 
 } print "the gene is not found \n\n\n"; 
print "try by converting this gene id into entrez id and use the entrez 
button to get the perfect results\n\n\n"; 
goto outside; 
} 
outside: 
} 
 
sub SOAP::Serializer::as_ArrayOfstring{ 
  my ($self, $value, $name, $type, $attr) = @_; 
  return [$name, {'xsi:type' => 'array', %$attr}, $value]; 
} 
sub SOAP::Serializer::as_ArrayOfint{ 
  my ($self, $value, $name, $type, $attr) = @_; 
  return [$name, {'xsi:type' => 'array', %$attr}, $value]; 
} 
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Sometimes Genbank Accession Identifiers are not found in KEGG pathways and 
consequently, these genes will not be highlighted on pathways although they may be present 
under a different identifier. To deal with this problem, code was written in Perl to search for 
entrez ID’s in all of KEGG’s pathways in the event of the Genbank analysis yielding no 
results.  
#!/usr/bin/perl -w 
open(FILE, "C:/mousekegg.txt"); 
my @array = <FILE>; 
print "                                  THE RESULTS    
 \n"; 
print "--------------------------------------------------------------------
------------\n\n\n"; 
my $count = 1; 
foreach my $array (@array) 
{print "\n$count ) the gene $count from the users data:\n\n\n"; 
 $count++; 
 print ("$array\n"); 
chomp ($array); 
  my @temp = split (/\s+/, $array); 
  for(my $j=1;$j<=1;$j++) 
 { 
   my $key = $temp[0]; 
print "\nusers input gene id is: $key\n\n"; 
 my $exprr = $temp[2]; 
 
print("HUGO name of the gene: $temp[1]\n\n"); 
print("mean expression of the gene: $exprr\n\n"); 
my @aaaa=split(//, $exprr); 
my $express=$aaaa[0]; 
 
 print "expression of the gene in users experiment : $express\n\n"; 
 if ($express eq "+") 
{ 
print "the gene is upregulated.\n\n"; 
} 
  elsif ($express eq "-") 
{ print "the gene is downregulated.\n\n"; 
} 
use Data::Dumper; 
use SOAP::Lite +trace => [qw(debug)]; 
 
 
my $serv = SOAP::Lite ->service("http://soap.genome.jp/KEGG.wsdl"); 
my $keggid=["mmu:".$key]; 
my $id = "mmu:".$key; 
my $arrayRef = $serv ->get_pathways_by_genes([$id]); 
my $final = Dumper $arrayRef; 
my @hifi = split(/'/, $final); 
A2.2 Analyzing Entrez Identifiers in KEGG pathways 
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my $size = @hifi; 
unless ($size == 0) 
{ 
for(my $i=1;$i<$size;$i=$i+2) 
 { 
my $keggpath = $hifi[$i]; 
print $keggpath, "\n\n"; 
if ($express eq "+") 
{ 
print "kegg pathway id is : $keggpath\n\n"; 
 
my $fg_list= ['green']; 
my $bg_list=['red']; 
my $extreme = $serv->get_html_of_colored_pathway_by_objects($keggpath, 
$keggid, $fg_list, $bg_list); 
print $extreme, "\n\n"; 
} 
elsif ($express eq "-") 
{ print "kegg pathway id is : $keggpath \n\n"; 
 
 $fg_list= ['red']; 
 $bg_list=['green']; 
 $extreme = $serv->get_html_of_colored_pathway_by_objects($keggpath, 
$keggid, $fg_list, $bg_list); 
print $extreme, "\n\n"; 
} 
}goto outside; 
} 
 print "\n\nthe gene is not found in KEGG pathways\n\n\n\n"; 
} 
outside: 
} 
 
sub SOAP::Serializer::as_ArrayOfstring{ 
 my ($self, $value, $name, $type, $attr) = @_; 
 return [$name, {'xsi:type' => 'array', %$attr}, $value]; 
} 
 
sub SOAP::Serializer::as_ArrayOfint{ 
  my ($self, $value, $name, $type, $attr) = @_; 
  return [$name, {'xsi:type' => 'array', %$attr}, $value]; 
} 
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MicroPath calculates the number of genes identified in a given pathway and 1) expresses this 
as a percentage in relation to the total number of common genes from the intersection and 2) 
expresses this as a percentage in relation to the total number of genes belonging to that 
pathway. The following code was written specifically for this function. 
 
#!/usr/bin/perl 
open(FILE, "C:/Perl/eg/userdata.txt"); 
my @inp = <FILE>; 
print "\n\n"; 
print "                                  THE RESULTS    
 \n"; 
print "--------------------------------------------------------------------
---------------------------------------------------------------------------
-----------------"; 
my $count = 1; 
$no = 1; 
@ array = (); 
@notfound = (); 
foreach my $inp (@inp) 
{ 
chomp ($inp); 
  @temp = split (/\s+/, $inp); 
  for(my $j=1;$j<=1;$j++) 
{ 
 $gene = $temp[0]; 
$val = $temp[1]; 
 
  $express = $temp[2]; 
use Data::Dumper; 
use SOAP::Lite +trace => [qw(debug)]; 
 
my $serv = SOAP::Lite ->service("http://soap.genome.jp/KEGG.wsdl"); 
my $rresult = $serv ->bconv("genbank:$gene"); 
my $length = length($rresult); 
unless($length==0) 
{ 
my @tem = split(/\s+/, $rresult); 
 for(my $k=1;$k<=1;$k++) 
{ 
my $iid = $tem[1]; 
 
  my $arrayRef = $serv ->get_pathways_by_genes([$iid]); 
 
my $final = Dumper $arrayRef; 
 my @hifi = split(/'/, $final); 
my $size = @hifi; 
 for(my $i=1;$i<$size;$i=$i+2) 
 { 
A2.3 Calculating percentage of genes from input that participate in X% of genes in 
a pathway 
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$keggpath = $hifi[$i]; 
 
  if($no>0) 
{ 
$strin = ($keggpath . "£" . $gene . "£" . $express . "£" . $iid); 
push(@array, $strin); 
} 
else { $si = @array; 
for($a=0;$a<$si;$a++) 
{ 
@pat = split(/£/, $array[$a]); 
while($pat[0]=~m/$keggpath/) 
{ 
$string = ($array[$a] . "£" . $gene . "£" . $express . "£" . $iid); 
splice(@array, $a, 1); 
push(@array, $string); 
goto side; 
} 
} $yd = ($keggpath . "£" . $gene . "£" . $express . "£" . $iid); 
push(@array, $yd); 
side: 
} 
 
 }goto outside; 
} 
} 
 
use Win32::OLE qw(in with); 
use Win32::OLE::Const 'Microsoft Excel'; 
$Win32::OLE::Warn = 3; 
 
my $Excel = Win32::OLE->new('Excel.Application', 'Quit'); 
 
my $Book = $Excel->Workbooks->Open("C:/Perl/eg/MMU.xls"); 
 
 
my $Sheet = $Book->Worksheets(1); 
foreach my $row (1..4829) 
{ 
for (my $col=3;$col<=3;$col++) 
 { 
 
  next unless defined $Sheet->Cells($row,$col)->{'Value'}; 
  my $id = $Sheet->Cells($row, $col)->{'Value'}; 
 
while ($id =~ m/$gene/) 
 { 
my $pathid = $Sheet->Cells($row,4)->{'Value'}; 
my $entrez = $Sheet->Cells($row,2)->{'Value'}; 
 my @pathway = split(/ /, $pathid); 
my $cize = @pathway; 
for (my $x=0; $x<$cize; $x++) 
{ 
$keggiid = ("mmu:".$entrez); 
$keggp = ("path:".$pathway[$x]); 
if($no>0) 
{ 
$strinn = ($keggp . "£" . $gene . "£" . $express . "£" . $keggiid); 
 
push(@array, $strinn); 
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} 
else { $si=@array; 
for($b=0;$b<$si;$b++) 
{ 
@patt = split(/£/, $array[$b]); 
while($patt[0]=~m/$keggp/) 
{ 
$stringg = ($array[$b] . "£" . $gene . "£" . $express . "£" . $keggiid); 
splice(@array, $b, 1); 
push(@array, $stringg); 
goto side; 
} 
} $yyd = ($keggp . "£" . $gene . "£" . $express . "£" . $keggiid); 
push(@array, $yyd); 
side: 
} 
} 
goto outside; 
  } 
 } 
} push(@notfound, $gene); 
outside: 
} 
$no=0; 
} 
use SOAP::Lite +trace => [qw(debug)]; 
my $serv = SOAP::Lite ->service("http://soap.genome.jp/KEGG.wsdl"); 
@jean=(); 
@obb=(); 
@blist = (); 
@flist = (); 
@expre=(); 
$num = 1; 
foreach $array (@array) 
{ 
@all = split(/£/, $array); 
$ize = @all; 
my $kepath = ($all[0]); 
for($n=3;$n<$ize;$n+=3) 
{ $ob = $all[$n]; 
push(@obb, $ob); 
$e = ($n-1); 
$je = ($n-2); 
$ex = $all[$e]; 
$ex = substr($ex, 0, 1); 
$jea = $all[$je]; 
if($ex eq "+") 
{ 
$fj ='green'; 
push(@flist, $fj); 
$bj = 'red'; 
push(@blist, $bj); 
push(@expre, 'upregulated'); 
push(@jean, $jea); 
} 
elsif($ex eq "-") 
{ 
$fj ='red'; 
push(@flist, $fz); 
$bj= 'yellow'; 
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push(@blist, $bz); 
push(@expre, 'downregulated'); 
push(@jean, $jea); 
} 
 
} 
$ci = @jean; 
$sy = @obb; 
if($sy==1) 
{ 
 $obj_list=[$obb[0]]; 
 $fg_list=[$flist[0]]; 
$bg_list=[$blist[0]]; 
  $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==2) 
{ 
 $obj_list=[$obb[0],$obb[1]]; 
 $fg_list=[$flist[0],$flist[1]]; 
 $bg_list=[$blist[0],$blist[1]]; 
  $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==3) 
{ 
 $obj_list=[$obb[0],$obb[1],$obb[2]]; 
 $fg_list=[$flist[0],$flist[1],$flist[2]]; 
$bg_list=[$blist[0],$blist[1],$blist[2]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==4) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==5) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==6) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==7) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
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t[6]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6]]; 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
} 
elsif($sy==8) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7]]
; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==9) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==11) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==12) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
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elsif($sy==13) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==14) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$ 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
} 
elsif($sy==15) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==16) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==17) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16]]; 
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$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
} 
elsif($sy==18) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17]]; 
 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17]]; 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
} 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==20) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19]]; 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20]]; 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
} 
elsif($sy==22) 
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{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21]]; 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
elsif($sy==23) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21],$obb[22]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21],$flist[22]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21],$blist[22]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==24) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21],$obb[22],$obb[23]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21],$flist[22],$flist[23]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21],$blist[22],$blist[23]]; 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
} 
elsif($sy==25) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21],$obb[22],$obb[23],$obb[24]
]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21],$flist[22],$flist[23],$flist[24]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21],$blist[22],$blist[23],$blist[24]]; 
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 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==26) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21],$obb[22],$obb[23],$obb[24]
,$obb[25]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21],$flist[22],$flist[23],$flist[24],$flist[25]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21],$blist[22],$blist[23],$blist[24],$blist[25]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==27) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21],$obb[22],$obb[23],$obb[24]
,$obb[25],$obb[26]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21],$flist[22],$flist[23],$flist[24],$flist[25],$flist[26]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21],$blist[22],$blist[23],$blist[24],$blist[25],$blist[26]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==28) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21],$obb[22],$obb[23],$obb[24]
,$obb[25],$obb[26],$obb[27]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21],$flist[22],$flist[23],$flist[24],$flist[25],$flist[26],$fl
ist[27]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21],$blist[22],$blist[23],$blist[24],$blist[25],$blist[26],$bl
ist[27]]; 
 $result = $serv->get_html_of_colored_pathway_by_objects($kepath, 
$obj_list, $fg_list, $bg_list); 
} 
elsif($sy==29) 
{ 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
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16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21],$obb[22],$obb[23],$obb[24]
,$obb[25],$obb[26],$obb[27],$obb[28]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21],$flist[22],$flist[23],$flist[24],$flist[25],$flist[26],$fl
ist[27],$flist[28]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21],$blist[22],$blist[23],$blist[24],$blist[25],$blist[26],$bl
ist[27],$blist[28]]; 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
$obj_list=[$obb[0],$obb[1],$obb[2],$obb[3],$obb[4],$obb[5],$obb[6],$obb[7],
$obb[8],$obb[9],$obb[10],$obb[11],$obb[12],$obb[13],$obb[14],$obb[15],$obb[
16],$obb[17],$obb[18],$obb[19],$obb[20],$obb[21],$obb[22],$obb[23],$obb[24]
,$obb[25],$obb[26],$obb[27],$obb[28],$obb[29]]; 
$fg_list=[$flist[0],$flist[1],$flist[2],$flist[3],$flist[4],$flist[5],$flis
t[6],$flist[7],$flist[8],$flist[9],$flist[10],$flist[11],$flist[12],$flist[
13],$flist[14],$flist[15],$flist[16],$flist[17],$flist[18],$flist[19],$flis
t[20],$flist[21],$flist[22],$flist[23],$flist[24],$flist[25],$flist[26],$fl
ist[27],$flist[28],$flist[29]]; 
$bg_list=[$blist[0],$blist[1],$blist[2],$blist[3],$blist[4],$blist[5],$blis
t[6],$blist[7],$blist[8],$blist[9],$blist[10],$blist[11],$blist[12],$blist[
13],$blist[14],$blist[15],$blist[16],$blist[17],$blist[18],$blist[19],$blis
t[20],$blist[21],$blist[22],$blist[23],$blist[24],$blist[25],$blist[26],$bl
ist[27],$blist[28],$blist[29]]; 
$result = $serv->get_html_of_colored_pathway_by_objects($kepath, $obj_list, 
$fg_list, $bg_list); 
} 
 
 
my @super; 
push(@super, "The genes involved in this pathway from user's input data : 
"); 
for($z=0;$z<$ci;$z++) 
{ 
 
push(@super, "user's input id : $jean[$z]\n\nkegg gene id : $obb[$z] "); 
   "; 
push(@super, "The pathway id is : $kepath "); 
 
push(@super, "The URL for the pathway is : "); 
push(@super, "$result "); 
my $totalgenes = $serv->get_genes_by_pathway($kepath); 
my $totnogenes = Dumper $totalgenes; 
my @totarray = split(/'/, $totnogenes); 
my $totarray; 
my @empty=(); 
for (my $new=1;$new<=$#totarray;$new+=2) 
{ 
push(@empty, $totarray[$new]); 
} 
my $totno = @empty; 
my $totinp = @inp; 
my $inpperc = ($ci/$totinp)*100; 
my $finpperc = sprintf("%.2f", $inpperc); 
 
push(@super, "The percentage of genes from the user's data involving in 
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this pathway is : $finpperc\% "); 
my $pathperc = ($ci/$totno)*100; 
my $fpathperc = sprintf("%.2f", $pathperc); 
 
push(@super, "$finpperc\% of genes from the user's data are contributing 
$fpathperc\% of role in this pathway. "); 
my $superr = join('£', @super); 
@super = (); 
$superfinal{$superr} = $fpathperc; 
$num = $num+1; 
@jean = (); 
@obb = (); 
@blist = (); 
@flist = (); 
@expre = (); 
} 
foreach my $value (sort {$superfinal{$b} cmp $final{$a} } 
keys %superfinal) 
{ 
my @superarray = split(/£/, $value); 
foreach my $superarray (@superarray) 
{ 
print("$superarray\n\n"); 
} 
print("\n------------------------------------------------------------------
--------------\n"); 
print("--------------------------------------------------------------------
------------\n\n\n"); 
} 
$saize = @notfound; 
if($saize>0) 
{ 
print "\nPathways were not found for the below genes\n\n"; 
foreach $notfound (@notfound) 
{ 
print $notfound, "\n\n"; 
} 
print "--------------------------------------------------------------------
------------\n"; 
print "Try by converting the above gene ids into entrez ids and use the 
entrez button from the interface to get the results\n\n"; 
print "--------------------------------------------------------------------
------------\n" 
} 
 
sub SOAP::Serializer::as_ArrayOfstring{ 
 my ($self, $value, $name, $type, $attr) = @_; 
 return [$name, {'xsi:type' => 'array', %$attr}, $value]; 
} 
sub SOAP::Serializer::as_ArrayOfint{ 
 my ($self, $value, $name, $type, $attr) = @_; 
return [$name, {'xsi:type' => 'array', %$attr}, $value]; 
} 
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